Wantstats
IndustriesCompaniesCharts & Stats
Leads DBAdvisoryPricingContact us
Login
/Company Profiles

Deep Intelligence Across Industries

All CompaniesFortune 500Aerospace & Defense iconAerospace & DefenseAgricultureAutomotive iconAutomotiveFinancial Services iconFinancial ServicesChemicals & Materials iconChemicals & MaterialsConsumer Goods iconConsumer GoodsEnergy & Power iconEnergy & PowerEquipment & Machinery iconEquipment & MachineryFood & Beverages iconFood & BeveragesHealthcare & Pharma iconHealthcare & PharmaInformation Technology iconInformation TechnologyManufacturing & ConstructionMRO iconMROProfessional Services iconProfessional ServicesSemiconductors

Showing 14441 companies

CROWNHAITAI

CROWNHAITAI Holdings Co., Ltd.

Premium
Information Technology

CROWNHAITAI Holdings is the apex listed holding company of Korea's third-largest packaged-confectionery group. It controls two listed operating companies, Crown Confectionery (KRX: 264900) and Haitai Confectionery & Foods (KRX: 101530). Through them it owns heritage brands including Crown Sando, Jolly Pong, Couque d'Asse, Big Pie, Honey Butter Chip, Home Run Ball, Oh Yes and Ace, and the Gohyang Mandu frozen-dumpling franchise. Consolidated revenue reached KRW 1,069.9 bn in FY2025. About 93% of revenue comes from confectionery, and more than 90% of sales are domestic, which sets the group apart from export-led rivals Orion and Lotte Wellfood. The holding company trades at a deep discount to book value (P/B about 0.2x). That discount reflects a family-controlled pyramid structure, thin returns on equity, a low-growth domestic market, and a governance overhang that intensified in September 2026. In that month the Securities and Futures Commission sanctioned subsidiary Haitai for overstating revenue by KRW 53.0 bn in 2016–2019. *Sources: StockAnalysis/S&P (financials, EV, price); Seoul Shinmun (4 Nov 2025) on ownership and history; Jasoseol public employer data (HQ address, employees); Google Finance (employees); StockHub (market cap, 23 Sep 2026).* --- ### What the company does CROWNHAITAI Holdings is a pure holding company. It does not manufacture products itself. It owns controlling equity stakes in operating subsidiaries and consolidates them, and it earns standalone income from dividends, brand/management fees and equity-method income. Public employer data shows standalone revenue of about KRW 18.2 bn. The company is classified under "financial and insurance (other financial)", but its listed product description names biscuits, chocolate, candy and wafers, reflecting the subsidiaries. Consolidated operations fall into three reporting blocks, as summarised by aggregators from the Q2 2026 report: **Confectionery (about 93% of revenue):** Crown Confectionery, Haitai Confectionery & Foods, and smaller food affiliates such as Family Foods (훼미리식품) and the Haitai-Calbee joint venture. **Other (about 5%):** Non-food subsidiaries including Kodi Service Korea (코디서비스코리아), Art Valley (아트밸리; stone/aggregates and a cultural complex in Yangju), CH Tech (씨에이치테크), Palazzo (빨라쪼; gelato) and Young Green (영그린). **Holding (about 1%):** The parent company's own revenue after eliminations. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue model | Almost entirely product sales of branded packaged foods (biscuits, snacks, chocolate, candy, pies, wafers, frozen dumplings). No meaningful subscription or licensing revenue at consolidated level. The parent earns royalties and management fees from subsidiaries, which are eliminated on consolidation | | Product vs service mix | About 93–95% product; about 5% "other" includes service-type revenue (e.g., Kodi Service Korea) and aggregates/cultural revenue (Art Valley). Exact service share n/d | | Value-chain position | Branded manufacturer. Raw materials (wheat flour, sugar, cocoa, dairy, oils, potatoes, packaging) are bought from third parties and processed in owned plants in Korea. Products are distributed through route sales, wholesale, hypermarkets, convenience stores (CVS), e-commerce and exports | | Customer types | Retail chains (hypermarkets, supermarkets, CVS), wholesalers and dealers, online platforms, export distributors in about 70 countries, and indirectly end consumers | | End-markets | Korean packaged confectionery (biscuits, savoury snacks, chocolate, sugar confectionery), Korean frozen foods (dumplings), and export markets (US, Japan, China, Australia, and newer markets in Central Asia/Mongolia and Canada) | ### Company self-description vs independent characterisation The company describes itself, as paraphrased from Korean employer-profile summaries of its disclosures, as a holding company overseeing group management and strategy for food and confectionery subsidiaries. It states a vision of customer delight, emphasises a return to the founding principle of providing safe and wholesome food, and frames ESG-based safety management as a source of competitiveness. **Independent characterisation.** Economically, CROWNHAITAI is a leveraged, domestically concentrated, mature branded-snack business wrapped in a family control vehicle. Its main assets are about 75 years of brand equity and a large owned manufacturing base: PP&E of KRW 720.0 bn at FY2025, including KRW 300.5 bn of land. Its main weaknesses are: - Thin margins (operating margin 3.9–6.9% across FY2021–FY2025). - Low plant utilisation (about 58–60% average). - Limited overseas production. - Value leakage to minority shareholders of the two listed subsidiaries. Minority interests took 46% of FY2025 consolidated net income. The holding company is effectively a "double discount" instrument: a holding-company discount layered on top of discounted listed subsidiaries. *Sources: Jasoseol company profile; IRGO (industry/product listing); Butler.works (segment split); Dealsite (14 Aug 2025); Economist.co.kr (subsidiary list, 2022); StockAnalysis/S&P.*

Revenue$0.8B
Employees77
Market CapN/A
Founded1947
United States, North America

Unlock Verified Contacts

Access verified employee contacts

Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.

USD650/mo
Buy Now

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
MR
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
BL
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
MI
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
RK
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
JL
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
AM
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Wantstats logo

Move faster. Think smarter. Win bigger.

Join our data driven community.

© 2026 All rights reserved by Wantstats Research and Media Pvt Ltd

footer vector

Pages

  • About
  • News
  • Charts & Stats
  • Contact
  • Ecosystem pricing
  • Privacy policy

Address

Wantstats Research and media Pvt. Ltd, Office No 104, Pentagon 4,
Magarpatta City, Pune - 411028,
Maharashtra, India.

Contact

support@wantstats.com

Follow Us

Follow Wantstats on FacebookFollow Wantstats on InstagramFollow Wantstats on LinkedInFollow Wantstats on YouTubeFollow Wantstats on WhatsApp
Crown

Crown Confectionery Co., Ltd.

Premium
Information Technology

Crown Confectionery is one of South Korea's oldest branded confectioners. It runs a domestic, mid-sized business with heritage brands, about KRW 445bn of FY2025 revenue and a 3–4% operating margin. Its portfolio covers sandwich biscuits (Crown Sando), wafer-rolls (Heim, Couque D'asse), chocolate pies (Big Pie), puffed-grain and corn snacks (Jolly Pong, C Corn Chip, Shinzzang) and soft candies (Mychew, Saekom Dalkom). Brand recognition is high, but it produces almost everything in three Korean plants: Daejeon, Jincheon and a new KRW ~70bn snack plant in Asan, completed in April 2024. Exports were only 6.4% of revenue in 2025. Crown is the founding company and listed sister of Haitai Confectionery & Foods inside the Crown Haitai group. The owner family controls it through a holding-company chain: Yoon Seok-bin → Dura Food → Crown Haitai Holdings → Crown Confectionery. The investment case turns on three things: pricing power against cocoa and input-cost inflation, filling a new plant that ran at about 61% utilisation in Q1 2026, and lifting its single-digit export share. A deep discount to book value (P/B about 0.47) partly offsets these factors. --- **What the company does.** Crown Confectionery makes, markets and distributes packaged confectionery in South Korea and exports a small share abroad. Its categories are biscuits and sandwich cookies, wafers, cream-filled cakes and pies, puffed and extruded snacks, crackers, soft and chewy candies, and chocolate-coated products. Third-party profiles describe the business as biscuits, wafers, snacks, pies, chocolates, sweets and gum (Morningstar). FMP/Wisesheets describe a portfolio of biscuits, cakes, snacks, candies and chocolates marketed under brands including Heim, Couque D'asse, Sando, Big Pie ("Vic Pie" in some English transliterations), Jolly Pong, C Corn Chip, Shinzzang and Mychew. **Company's own description.** The company does not publish an English annual report. In local press materials and its plant-opening communications, it presents itself as a leading Korean confectioner built on its founding philosophy that food is the foundation of life. It cites Crown Sando, Jolly Pong, Corn Chip and Big Pie as household brands (NewsSeoul, May 2024, paraphrased). Recruitment-portal summaries drawing on its filings describe it as a domestic confectioner that was established in 2017 through the demerger from Crown Haitai Holdings and that grows on stable domestic sales (JaSoSeol, 2026). **Business model and revenue model.** The revenue model is entirely product sales. It has no subscriptions, licensing or meaningful service revenue. In the 2026 interim period (Q2 2026 revenue basis), revenue split as follows (Butler.works, from DART business-section data): The 15% "merchandise" line shows that Crown sells some products it does not make itself, for example rice-cracker ranges such as Chamssal Seolbyeong and Seongwa sold under its brand. The source data does not say whether these are made by an affiliate or a third party. This is NV. **Value-chain position.** Crown is a branded manufacturer. It sits between commodity input suppliers (wheat flour, sugar, edible oils, cocoa and chocolate compounds, dairy, nuts, corn) and retail channels. It imports cocoa-based raw materials; dealsite (May 2025) reported their unit price up 24.3% year on year in Q1 2025. Crown does not run retail stores. Group distribution and logistics are centralised; the new Asan plant houses a robotic logistics centre that the company describes as a national snack logistics hub (Bizwatch, Aug 2022). **Customer types and channels.** Customers are mainly trade customers: hypermarkets, supermarkets, convenience stores, wholesalers and agents, e-commerce (Crown runs official brand stores on Coupang and Gmarket) and specialty channels (for example, a pre-sale on CJ Olive Young for Mychew Tomato in May 2026). Export customers are importers and distributors in roughly 70 countries at group level; the main hubs are Australia, the United States and China (TF News, May 2026; Financial News, May 2026). **End-markets served.** End-markets are Korean packaged sweet and savoury snacks and confectionery, plus a small export business. Demand comes from children, students and families, convenience snacking, gifting and "retro" nostalgia, and a growing young-adult "dessert" segment that Crown targets with limited-edition flavours such as matcha, apricot, ube and tomato. **Independent characterisation.** Crown is a domestic, heritage-brand, mid-cap confectioner. It has almost no overseas production. Its margin is structurally thin: operating margin has stayed between 3.4% and 6.5% over FY2021–FY2025. Earnings are highly sensitive to commodity costs and to when it takes price increases. It competes against two much larger, more international peers (Lotte Wellfood and Orion) and shares a holding company with Haitai, the group's larger sister company. Crown has generally relied on cost control, raw-material substitution and limited-edition line extensions rather than large innovation launches or M&A.

Revenue$0.3B
Employees1,306
Market CapN/A
Founded1947
United States, North America
Creverse

Creverse, Inc.

Premium
Information Technology

Creverse is a Seoul-based provider of premium after-school education ("hagwon") to Korean children from preschool through high school, built on the 2022 merger of English-academy operator Chungdahm Learning and math/coding gifted-education specialist CMS Edu. Its brands, including Chungdahm Institute (with the exam-oriented THE OPEN sub-brand), April Institute, iGARTEN, CMS Gifted Education Center, CMS Gifted Academy (영재관) and C-Cube Coding, are delivered through a mix of directly operated and franchised campuses, supported by proprietary curricula, blended online learning and a growing AI layer led by the HUMMINGo automated English-writing assessment engine. The company sells to parents (B2C tuition), to franchisees (royalties and materials) and, on a small scale, to overseas partners (curriculum and IP licensing, chiefly in Vietnam). Its investment case rests on brand strength in the upper tier of the market, high cash returns to shareholders and an earnings recovery, set against a shrinking school-age population and a leveraged balance sheet inherited from the merger. --- ### What the company does | Reported line | Entity | Content (as described in the filing) | |---|---|---| | Domestic education business | Creverse, Inc. | Directly operated academies (Chungdahm Institute, THE OPEN Chungdahm, April Institute, iGARTEN, CMS Gifted Academy, CMS Thinking-Skills Center, C-Cube Coding); metaverse English and math platforms BOUNCY and NOISY; franchised academies (Chungdahm, April, iGARTEN, CMS Thinking-Skills, C-Cube Coding); META-Learning and i-Learning online services; sale of textbooks and teaching aids to direct and franchise academies; other education services and rental income | | Overseas education business | Creverse, Inc. | Supply of curricula to overseas partners: SCOTS ENGLISH, KIEN GURU and VUIHOC EDU (Vietnam), Xin Nanyang (China), Global Vision (Japan) | | English academy business | Boda Naeun Co., Ltd. (51% subsidiary) | Directly operated / franchised Chungdahm and April academies (Dongtan 2 area) | Creverse operates premium private academies in three subject areas: English, mathematics (thinking-skills and gifted/olympiad math) and coding. The company presents itself as a "convergence thinking-skills education platform" that combines language, mathematics and computing. Its own English-language website describes the offering as English, math and coding education spanning offline classrooms and virtual environments (company.creverse.com). The Q1 FY2026 quarterly report filed on KIND (15 May 2026) describes the business in three reporting lines: ### Business and revenue model Revenue comes from four sources: 1. **Tuition from directly operated academies.** This is the largest source. Academy tuition was 54.2% of revenue in FY2022 (News Tomato, Mar 2023). 2. **Franchise income.** Royalties and fees from franchised Chungdahm, April, iGARTEN, CMS and C-Cube campuses. 3. **Materials sales.** Textbooks and teaching aids sold to direct and franchise academies. 4. **Licensing and other.** Curriculum/IP licensing abroad, online learning services, AI solutions (early stage) and rental income. A precise product / service / subscription / licensing split for FY2025 is ND in sources reviewed. The model is service-led and seasonal. Enrolment is driven by four academic terms: spring (Mar–May), summer (Jun–Aug), fall and winter. Spring is the main recruitment season, and summer revenue typically dips because of final exams and holidays (company Q2 FY2026 release, Aug 2026). ### Value-chain position, customers and end-markets Creverse is vertically integrated. It develops curricula and content in-house (R&D center and the AX/Nesto CV AI division), publishes its own materials, runs flagship direct campuses and extends reach through franchisees. Customers are Korean households with children aged roughly 5 to 16+ (iGARTEN for ages 5–7; April for lower elementary; Chungdahm for grades 3 to first year of high school; CMS from early elementary through high school via the 2026 "Climath" high-school program). The end-market is the Korean private supplementary education (사교육) market, concentrated in high-income education districts (Daechi-dong, Mokdong, Bundang, Dongtan, Busan), plus a small B2B licensing market in Southeast Asia and emerging AI-assessment opportunities in Korean public education and Gulf (GCC) K-12 schools. ### Independent characterization Creverse is best understood as a premium, brand-led, offline-first academy operator whose economics depend on campus enrolment and price points in a structurally shrinking student market. Since 2022, its strategic problem has been that cross-selling English and math students across merged brands did not work as planned. Management acknowledged in a November 2025 interview that the market's response to its cross-enrolment push fell short of expectations. Meanwhile, merger-related borrowing left the balance sheet stretched. FY2025–FY2026 has been a restructuring phase with four elements: brand renewal (THE OPEN, April α, a redesigned CMS roadmap), cost cuts, real-estate sale-and-leasebacks to reduce debt, and an AI pivot to lower grading costs and create a new B2B/B2C product line. Overseas revenue is immaterial at under 1% of sales.

Revenue$0.2B
Employees976
Market CapN/A
Founded1998
United States, North America
CreasF&C

Creas F&C Co., Ltd.

Premium
Information Technology

Creas F&C is South Korea's largest dedicated golf-apparel company by revenue. It is widely described as the domestic No.1 in a market that the industry press estimates was the world's largest golf-fashion market [S21][S23]. Its portfolio started with a PING apparel licence in 1999. It now runs a tiered set of licensed and owned golf brands: PING (premium/mature), PEARLY GATES (fashion-forward, youth), MASTER BUNNY EDITION (performance), FANTOM (mass/value) and St ANDREWS (high-end). These are sold through about 660 department-store, franchise, directly operated and outlet doors plus online channels [S15]. After the pandemic golf boom ended, revenue fell from KRW 380.9bn (FY2022) to KRW 311.9bn (FY2025), and the company posted a consolidated operating loss in FY2025 [S1][S5]. Management has reacted in three ways: diversifying into outdoor (owned brand HYDROGEN; Korean licences for MAMMUT and and wander), vertically integrating into golf-course operation (Creas Valley CC, opened 2025–26), and, since 2025, disposing of non-core stakes to repair the balance sheet [S11][S16]. The shares trade at under 0.2x book. --- ### What the company does Creas F&C designs, sources and sells branded golf apparel and related accessories in South Korea, and more recently premium outdoor apparel and equipment. The company's own filings describe its business purpose as the manufacture and sale of apparel [S7]. Morningstar summarises the business as men's and women's golf wear plus related products [S32]. Aggregator descriptions list the brand roster as PING APPAREL, FANTOM SPORT, PEARLY GATES, MASTER BUNNY EDITION, St. ANDREWS, HYDROGEN, GOKER and VESSEL [S32]. Since late 2025 a second reportable activity, golf-course operation, has appeared through wholly owned subsidiary Creas Valley Co., Ltd. ((주)크리스밸리). It accounted for about 4% of revenue in Q2 2026, with apparel manufacturing and sales at about 96% [S5]. ### Business model The core model is brand licensing plus in-house design and outsourced production: **Licensed brands:** PING (from Ping Inc., USA, since December 1999), PEARLY GATES and MASTER BUNNY EDITION (Japanese brands), St ANDREWS (Scottish-origin brand), MAMMUT (Swiss outdoor, exclusive Korean rights through December 2029) and and wander (Japanese outdoor, exclusive Korean rights from 2024) [S15][S17][S28]. Licence royalty terms are not publicly disclosed in sources reviewed. **Owned brands:** FANTOM (acquired and relaunched; acquisition year not disclosed in sources reviewed), HYDROGEN (Italian brand; 100% of Hydrogen S.R.L. acquired May 2022) and smaller labels such as VESSEL and GOKER [S16][S32]. **Production:** Largely outsourced to contract manufacturers. A 2022 attempt at vertical integration, buying 21.82% of apparel OEM Kukdong (later renamed Ontide), was reversed in 2025 [S12][S14]. **Distribution:** A multi-channel domestic network. At IPO in 2018 the company had 523 offline stores [S13]. By November 2023 it reported 664 stores, comprising 134 department-store doors plus 337 directly operated and agency (franchise) stores, with the balance outlets and other formats [S15]. Online channels comprise the in-house platform Bucket Store (spun off from "Creas Mall" in February 2022), third-party platforms (Musinsa, 29CM) and TV home shopping [S27][S39]. **Golf-course operation:** Creas Valley CC is an 18-hole public course in Anseong, Gyeonggi-do. The company presents it as both a profit centre and a marketing asset for tournaments and brand exposure [S19][S20]. ### Revenue model mix | Revenue type | Description | Approx. share | Basis | |---|---|---|---| | Product sales (apparel and accessories) | Wholesale to franchise stores; retail via department stores (concession model), direct stores, outlets, online | ~96% | Q2 2026 [S5] | | Golf-course operation | Green fees, carts, F&B at Creas Valley CC | ~4% | Q2 2026 [S5] | | Licensing out / royalties | Not material / not disclosed | n/d | — | | Rental income | Minor rental income historically noted alongside apparel sales | Immaterial | FY2021 Q1 [S38-adjacent TIN News] | In Q1 2021, clothing was 99.81% of product sales, golf balls and merchandise were 0.19%, and exports were negligible (KRW 0.11bn) [TIN News, S-list]. This confirms an almost entirely domestic, apparel-only revenue base before the outdoor and golf-course diversification. ### Value-chain position Creas sits in the brand-owner / brand-licensee and retailer layer of the apparel value chain. It controls design, merchandising, marketing (tour-player sponsorships, K-pop endorsements, KLPGA title sponsorship) and distribution, and it outsources fabric and garment production. Its economics depend on gross margin (58.8% in FY2025, down from 68.6% in FY2023) and on department-store commission and store operating costs captured in SG&A (60.3% of revenue in FY2025) [S1, derived]. ### Customers and end-markets **Customers:** Korean retail consumers, mainly golfers and golf-lifestyle buyers aged roughly 20s to 60s+, segmented by brand. Franchise operators are intermediate customers on the wholesale side. **End-markets:** (1) Korean golf apparel, estimated at KRW 4.25tn in 2022, KRW 3.75tn in 2023 and KRW 3.45tn in 2024 [S22]; (2) Korean premium outdoor and gorpcore apparel; (3) Korean public golf-course operation; (4) small overseas retail footprint for HYDROGEN in Japan, Hong Kong and Singapore, with a China entry MOU signed in 2025 [S9][S18]. ### Independent characterisation Creas is a domestic, single-category, brand-portfolio apparel house whose results correlate strongly with Korean golf-participation cycles. Hanwha Research ran an explicit regression of Creas revenue against golf-course visitor numbers in 2020 [S-Hanwha]. The company scaled efficiently through the 2020–2022 boom, with FY2021 operating margin of about 23%. It has since de-rated as the cycle turned and as it spent capital on three things at once: outdoor brand launches, a golf-course build, and a series of minority investments in unrelated listed and unlisted companies. The current equity story is a deep-value, asset-backed turnaround rather than a growth story. Book equity is far above market value, and the key uncertainty is whether management allocates capital in ways that close that gap.

Revenue$0.2B
Employees290
Market CapN/A
Founded1998
United States, North America
COSON

COSON Co., Ltd.

Premium
Information Technology

Yuhan Cosmetics, formerly COSON, is a small South Korean cosmetics OEM/ODM manufacturer that is being rebuilt by its controlling shareholder, Yuhan Corporation, one of Korea's largest pharmaceutical companies. Between 2014 and 2019, COSON grew from a reverse-listed DVR maker into a top-tier colour-cosmetics contract manufacturer, peaking at roughly KRW 109 bn of revenue in FY2019. Its growth came from co-developing YG Entertainment's Moonshot brand (including the "GD Cushion"), private-label supply to MINISO through a Guangzhou subsidiary, and China-facing distribution. The 2017 THAAD retaliation, failed brand ventures, COVID-19, three consecutive audit disclaimers (FY2020–FY2022), court rehabilitation (2022–2023) and KOSDAQ delisting (October 2023) collapsed the business. FY2025 revenue was about KRW 1.9 bn against an operating loss of KRW 5.8 bn. Equity was negative KRW 27.8 bn at end-Q1 2026. The investment case now rests on Yuhan's continued funding and on whether the "Trusted Science, Beautiful Solutions" pharma-linked ODM repositioning can win new customers. --- ### What the company does Yuhan Cosmetics develops and manufactures cosmetic products under contract for brand owners (OEM: manufacturing to the customer's formula; ODM: the manufacturer develops and proposes the formula). Historically the product scope covered both skin care and colour cosmetics. Simply Wall St's description lists skin-care formats (solubilised products, masks, cleansing, emulsions, sun care) and make-up formats (emulsion-based, lip and powder products). Trade databases also record BB and CC creams. ### Company's own description (paraphrased) At the October 2025 renaming, the company set out a vision of "Trusted Science, Beautiful Solutions." It says it will combine Yuhan Corporation's accumulated scientific research know-how with cosmetics development, offering an end-to-end service from product planning through R&D, production and quality control. It named three core values: Innovation First, Trusted Partnership and Sustainable Growth. It also named excellence, scientific approach and partnership as guiding principles, and committed to continued R&D investment (Herald Economy; Hankyung, Oct 2025). ### Independent characterisation On the evidence, the company today is a sub-scale, loss-making contract manufacturer in turnaround. Revenue in FY2025 (KRW 1.9 bn) was about 1.7% of its FY2019 peak (KRW 109.3 bn). Quarterly revenue in 2026 has run at about KRW 0.4 bn, while quarterly operating losses have been KRW 0.9–1.4 bn (Dailypharm, Jul 2026). Its balance sheet is fully impaired (equity of negative KRW 27.8 bn at end-Q1 2026). The business continues because Yuhan Corporation keeps injecting equity: KRW 105 bn... correction, KRW 10.5 bn across three issues in 2025, and KRW 5.0 bn approved in July 2026. The model has two strands: 1. **B2B contract manufacturing (core).** Revenue is per-unit manufacturing fees, with margins driven by plant utilisation. 2. **Own-brand B2C (nascent).** The subsidiary Yucostory sells the "The Yu" (더이유) brand on Naver Smart Store; Yuhan Cosmetics manufactures it (Mar 2026). ### Revenue model mix | Revenue stream | Share of revenue | Status | |---|---|---| | Product manufacturing (OEM/ODM) | Not publicly disclosed; historically the large majority | Core | | Own brands (Moonshot co-venture historically; The Yu from 2026) | Not publicly disclosed | Nascent | | Services / subscription / licensing | None disclosed | — | ### Value-chain position and customers The company sits in the mid-stream of the beauty value chain. It buys raw materials and packaging, formulates and fills, and supplies finished goods to brand owners, who handle marketing and retail. Named historical customers and partners include: - YG Entertainment's Moonshot brand (development and production); - MINISO private-label products and the Chinese colour brand "Wushenji" (우센지) via the Guangzhou subsidiary (2017); - Guangzhou Huanya Cosmetics (distribution partner, 2014); - apM Group (Dongdaemun) private-label and collaboration products (2016); - a US consignee, Astral Health and Beauty, which received shipments through June 2023 (Panjiva). ### End-markets Mass and masstige skin care and colour cosmetics, sold domestically through retail, duty-free and online channels, and exported through brand customers, historically with heavy exposure to China.

Revenue$0.0B
Employees39
Market CapN/A
Founded1992
United States, North America
Cosmax

Cosmax, Inc.

Premium
Information Technology

Cosmax, Inc. is the world's largest cosmetics original development manufacturer (ODM) by revenue. It formulates, develops and mass-produces skincare, makeup, hair, body and sun-care products that other companies sell under their own brands. Its client base spans global multinationals such as L'Oréal, a supplier relationship since 2004, and thousands of fast-moving Korean, Chinese, Southeast Asian and US "indie" brands. FY2025 revenue was a record KRW 2,398.8 bn (about USD 1.66 bn), and operating profit was KRW 195.8 bn. Cosmax runs production in Korea, China, the United States, Indonesia, Thailand and, since April 2026, Italy, with stated capacity of about 2.69 bn units a year. The equity story rests on the structural globalisation of K-beauty. Cosmax acts as an outsourced R&D and manufacturing engine behind much of it, and it is widening its model from pure ODM into raw-material design, OBM brand-building services, and co-innovation with L'Oréal. --- ### Company self-description Cosmax describes itself as a global cosmetics R&D and production (ODM) company that researches, develops and manufactures cosmetics in Korea and overseas. In its DART filing the company states its business as cosmetics, customised cosmetics and other, covering skincare, base makeup, colour makeup, herbal cosmetics, fragrance and hair care (summary of the company profile used in Korean brokerage data). In its 2026 investor materials the company describes supplying more than 4,000 brands in more than 100 countries, with over 90% of sales from ODM contracts (Q2 2026 earnings summary via Quartr). Press materials also cite about 5,000 client companies (Kukinews, Dec 2025; Fortune 2026). ### Business model **ODM (core, >90% of sales):** Cosmax develops the formula, often proposing finished concepts, textures and claims. It then produces the product at its own plants for the brand owner. Revenue is recognised per unit shipped. Pricing is negotiated product by product and is not publicly disclosed. **OEM:** Cosmax manufactures to a formula supplied by the client. This share has declined over time; in the US the ODM share reportedly reached about 80% by 2024 (Dealsite, Sep 2024). **OBM (original brand manufacturing):** a newer service layer in which Cosmax supports brand planning as well as R&D and manufacturing. It is active in Thailand since H2 2025 and is being extended group-wide (Dealsite, Nov 2025; Herald Business, 2026). **Ancillary platforms:** an export-support platform that helps clients with customs, tariffs and logistics for direct exports; a packaging sourcing platform ("Cosmax Package.com"); and customised-cosmetics/AI personalisation capabilities (TheVC; Newdaily, Mar 2025; Kukinews, May 2025). **Revenue model mix:** effectively 100% product revenue (manufactured goods). There is no material subscription, licensing or service revenue line in the sources reviewed. ### Value-chain position Cosmax sits between raw-material and packaging suppliers upstream and brand owners and retailers downstream. It manages about 200 strategic suppliers under an ESG programme (Kukinews, Mar 2025). It is pushing upstream into proprietary raw-material development, which the company says cuts costs by about 30% versus imported materials (Sidae, Mar 2026). ### Customer types and end-markets **Global multinationals:** L'Oréal (since 2004); Fortune also names Shiseido, Yves Saint Laurent and Lancôme. **Korean indie and mid-size brands:** brokers name APR, The Founders, Mediheal, Jung Saem Mool and Clio among recent growth drivers (Hana Securities, Jul 2026; SK Securities, Oct 2026). **Chinese domestic brands:** historically Florasis (Huaxizi), Perfect Diary and Ziranzhai (Dealsite, Mar 2022). **Southeast Asian brands:** for example Mistine in Thailand (Maeil Business, Jun 2018). **US indie brands:** West Coast clients are served through a California sales office (FY2025 results release). End-markets are prestige and mass skincare, colour cosmetics, sun care, hair and body care, and derma/medical-device cosmetics (via Keminova). Products sell through online, Health & Beauty stores, duty-free, modern and general trade in Southeast Asia, and export channels. ### Independent characterisation Cosmax is best understood as a capacity-plus-formulation-library platform whose growth tracks two things: (i) the number of brands launching products, especially asset-light indie brands that cannot afford in-house R&D, and (ii) the speed at which Korean-designed products are exported. The Korean entity is the profit engine (KRW 154.6 bn of the group's KRW 195.8 bn FY2025 operating profit). Overseas subsidiaries have historically diluted margins, and the US has diluted capital as well. The investment case in 2026 is shifting from "Korea carries the group" to "all regions contribute", following the US unit's first quarterly operating profit in Q2 2026.

Revenue$1.7B
EmployeesN/A
Market CapN/A
Founded1992
Registered seat in Hwaseong, South Korea
COPUSKOREA

COPUS KOREA Co., Ltd.

Premium
Information Technology

COPUS KOREA is a small-cap Korean content company. For most of its 20-year history it was a specialist distributor of Korean dramas and variety shows into Japan. It acquired Korean broadcast rights, then localised them: subtitling, music-rights clearance and technical conversion. It resold them to Japanese broadcasters, DVD labels and OTT platforms, including Amazon Prime Video Japan. Its 2022 acquisition of Kim Jong-hak Production, the studio behind *Sandglass*, *Full House* and *All of Us Are Dead*, added drama production. The company also co-produces with SLL (JTBC Studios). Global OTT platforms began licensing Korean content directly, and the Japanese local-OTT market weakened. Revenue held at KRW 41.8 bn in FY2024, but large content-rights write-downs produced an operating loss of KRW 29.4 bn that year. FY2025 revenue fell to KRW 32.9 bn. After a failed 2025 sale process, a delisting-risk squeeze and a 5:1 reverse split, the company was recapitalised in mid-2026. A consortium led by Artist Studio, part of the Lee Jung-jae/Jung Woo-sung "Artist Company" group, took control. It now pitches Copus as the distribution arm of a vertically integrated studio. --- ### What the company does The company has historically described itself as a "Hallyu (Korean Wave) content specialist" running two divisions (Hanyang Securities, Nov 2023): 1. **Distribution (배급).** Copus acquires licences for Korean dramas, variety shows and films from Korean broadcasters and producers. It customises them for the Japanese market, including subtitles, music-rights clearance, encoding and QC. It then supplies them to Japanese terrestrial and cable broadcasters, DVD distributors and OTT platforms (SK Securities, Jul 2021). In 2021 it also began operating a Korean-content channel inside Amazon Prime Video Japan, with revenue sharing on subscriptions (SK Securities, Jul 2021; Hi Investment, Sep 2021). 2. **Production (제작).** Copus develops and co-produces dramas, mainly through its wholly owned subsidiary Kim Jong-hak Production, acquired July 2022. Co-production partners include SLL (JTBC Studios), Monster Union and Chorokbaem Media. Revenue is recognised on a percentage-of-completion basis as dramas are produced and delivered (Meritz, Jan 2023). 3. **Ancillary / new media.** Webtoon and web-novel development (e.g., Naver Webtoon serialisation from 2022), audiobooks, and short-form vertical drama through the Hyper Epic JV with Bamboo Network. Third-party localisation and technical services are also offered: digital encoding, subtitling, broadcast-format conversion, archiving, QC and video editing (Simply Wall St company description; Asia Economy, May 2024; Dealsite, Sep 2025). ### Company's own description (paraphrased from DART-based summaries) The latest business summaries describe Copus as a content distribution and production company founded in 2005 and listed via SPAC merger in 2020. It has four consolidated subsidiaries including its Japanese entity, and it strengthened production capacity by acquiring Kim Jong-hak Production in 2022 (WiseReport company overview, Sep 2026). The August 2026 EGM added several new business objects to the articles: character/IP merchandising, content-linked product planning, live commerce and content commerce, and digital subscription services (Dealsite, Aug 2026). ### Revenue model | Revenue stream | Model | Commentary | |---|---|---| | Japan licensing (broadcast / DVD / OTT) | Licence fees, typically multi-year windows | Copus prepays or buys rights, capitalises them as intangible assets (content rights) and amortises them through cost of sales. When the resale value of acquired rights collapsed in 2024–25, this produced heavy write-downs (Dealsite, Apr 2026) | | OTT channel operation (Amazon Prime Video Japan) | Revenue share on channel subscriptions | Started 2021 (Hi Investment, Sep 2021) | | Drama production | Production fees from broadcasters/platforms (e.g., SLL/JTBC, Netflix), recognised by progress | Lumpy, slate-dependent. Production revenue was KRW 17.2 bn in 1H2024 and KRW 1.6 bn in 1H2025 (The Bell, Oct 2025) | | Webtoon / web novel / audiobook | Platform revenue share | Immaterial to group revenue (not separately disclosed) | | Short-form drama | JV revenue (Hyper Epic) | Not separately disclosed | The mix is product/licensing plus project-based production. There is no meaningful subscription revenue of its own (the Amazon channel is revenue-share), and no licensing-out of proprietary technology. ### Value-chain position, customers and end-markets **Value-chain position:** Historically a mid-stream intermediary between Korean rights-holders (KBS, MBC, SBS, tvN/CJ ENM, JTBC/SLL, independent producers) and Japanese platforms. It has moved upstream into production since 2022. **Customer types:** Japanese broadcasters, DVD distributors, Japanese local OTTs and global OTTs operating in Japan (Amazon Prime Video), Korean broadcasters/studios (SLL Joongang was counterparty to the *New Employee Chairman Kang* supply contract, DART 26 Nov 2025), and Netflix (via co-productions). **End-markets:** The Japanese consumer video market (K-content segment) and the Korean/global premium-drama market. ### Independent characterisation Copus is a sub-scale, single-geography licensing intermediary whose moat has eroded. Its historical edge rested on rights-clearance know-how and relationships in Japan. Copus claimed No.1 share of K-content distribution in Japan in 2020 (company statement via Asia Economy, Nov 2020). Global OTTs bypassed that intermediary role by commissioning or licensing directly from Korean studios, and Japanese local OTTs lost subscribers to global platforms. This left Copus holding rights acquired at peak prices (The Bell, Oct 2025). The production pivot, through Kim Jong-hak Production and SLL co-productions, has produced creditable hits: *The Tale of Lady Ok*, and *New Employee Chairman Kang*, which peaked at 13.6% nationwide on JTBC. However, the business is too small to absorb slate gaps. The new owners' thesis is that Copus becomes the Japan/overseas distribution node of the Artist Studio–Studio Jidam group. That thesis is unproven, and the acquirer itself is loss-making (Aju Business Daily, Jul 2026).

Revenue$0.0B
Employees12
Market CapN/A
Founded2005
United States, North America
Conduit

Conduit Capital Limited

Premium
Information Technology

Conduit Capital is a small South African investment holding company. After 2015 it was rebuilt as a value-investing insurance holding company on a "float plus equity portfolio" model. In practice it was dominated by one operating asset: the Constantia Insurance Group. Constantia was a niche short- and long-term insurer writing health, medical malpractice, specialty and general property-and-casualty, funeral and assistance business in South Africa and 18 other African countries. CICL generated about 94.4% of group revenue (H1 FY2022). It was placed under curatorship by the Prudential Authority in July 2022 and into provisional liquidation in September 2022. That left Conduit with a run-off life insurer, minority private stakes and a portfolio of legal claims and disputes. Its management now pursues a stated strategy of realising assets and cutting costs. The JSE removed the listing in December 2025 after more than three years of suspension. Conduit is best understood today as a sub-scale, unlisted wind-down vehicle with contingent litigation assets and liabilities. It is no longer an operating insurer. --- ### The company's own description In IAR22, Conduit describes itself as a listed investment holding company on the JSE Limited, incorporated and domiciled in South Africa. Its stated vision is to grow long-term intrinsic value per share faster than the market average and ahead of its peers. The company website describes a vision of building a diversified investment group. It says the group operates mainly through two internal investment strategies, Insurance and Private Investments. ShareData's summary fact sheet, which predates the liquidation, describes Conduit as an investment holding company whose subsidiaries mostly operate in Southern African insurance. That earlier aim was to build a diversified insurance investment group alongside a non-insurance, value-oriented portfolio. ### Business model as it operated (2015 – July 2022) From June 2015 under CEO Sean Riskowitz, Conduit ran on a model modelled on Berkshire Hathaway. A Value Investors Club write-up in September 2016 called it a "mini-Berkshire": 1. **Insurance float generation.** Constantia wrote niche gross premium through underwriting management agencies (UMAs), brokers and agents. Much of the risk was ceded under "solvency relief" reinsurance arrangements. These arrangements cut net written premium sharply but also cut the regulatory capital Constantia needed to hold. At 31 December 2021, float was R618.2 million (Interim H1 FY2022). 2. **Value-investing capital allocation.** Float and shareholder capital were invested on Graham and Buffett principles: fractional ownership, "Mr Market", margin of safety and circle of competence (IAR22, section III). The listed equity portfolio was valued at R125.2 million at 31 December 2021. 3. **Private investments.** These included 51% of Century 21 South Africa, Africa Special Opportunity Capital (ASOC) Fund I, insurtech stakes held through Conduit Ventures, and a 30% stake in Oraclemed Health Investments (acquired for R42.0 million in H1 FY2022). ### Revenue model | Revenue type | Description | Status | |---|---|---| | Insurance premium (short-term) | Gross premium on health, medical malpractice, P&C specialty, P&C general, guarantee, liability and assistance business written by CICL | Ceased July 2022 (curatorship, then liquidation) | | Insurance premium (long-term) | Life, funeral and group risk through Constantia Life Limited (CLL) and Constantia Life & Health Assurance Company (CLAH) | CLL in run-off; CLAH sale to Affinity Financial Services (R20 million) announced December 2022, completion not confirmed in sources reviewed | | Investment income | Dividends, interest and fair-value movements on listed and unlisted holdings | Ongoing on a reduced asset base | | Franchise / brokerage income | Consolidated through the 51% stake in Century 21 South Africa (master franchise) | Status after 2022 not publicly disclosed | | Commissions / administration | Earned through Constantia Risk and Insurance Holdings (CRIH) group entities | Largely ceased | The model was transactional insurance underwriting. There was no subscription or licensing revenue. In the value chain, CICL was a risk carrier: the licensed insurer behind third-party UMAs and binder holders. The group also held minority stakes in some of those distribution and claims businesses through Conduit Ventures. ### Customer types and end markets Constantia insured individuals (gap cover and primary health products, funeral and life), professionals (medical practitioners through the EthiQal medical malpractice book), and institutions and corporates (guarantees, liability, specialty P&C, motor and property). Business was written in South Africa and, at the time of the curatorship, in 19 African countries in total including South Africa. The Star newspaper (2 August 2022) and the H1 FY2022 interim report both give this footprint. ### Independent characterisation As an analyst, I would describe Conduit before 2022 as a leveraged bet on an under-capitalised niche insurer, paired with a concentrated small-cap equity portfolio. The pairing hurt the group. Constantia's underwriting turnaround (FY2022 combined ratio below 100% and the first net underwriting profit since 2016, per the 13 June 2024 trading statement) kept being offset by mark-to-market losses in the listed portfolio. The insurer's solvency also depended on external recapitalisation that never arrived: the Trustco/LSH deal (2019–2020) and the Mmuso Consortium deal (2021–2022) both failed. After July 2022, Conduit stopped being an operating insurance group. What remains is a residual holding company. Its value depends on (a) recovering an arbitration award of R50 million plus interest against Trustco Property Holdings, (b) disposing of or transferring the run-off life insurer CLL, and (c) the outcome of a R37.4 million claim from the CICL liquidators.

RevenueN/A
Employees8
Market CapN/A
Founded1993
United States, North America
Com2uS

Com2uS Holdings Corporation

Premium
Information Technology

Com2uS Holdings is the listed business-holding company at the top of the Com2uS Group. It was founded in 2000 as Gamevil, one of Korea's pioneering feature-phone and then smartphone game publishers. Today it combines three things. First, it runs its own global game-publishing operation, centred on the idle RPG *Soul Strike*, the *Zenonia* IP and a 2026 slate of more than ten mobile, PC and console titles. Second, its subsidiary Com2uS Platform sells *Hive*, a game backend-as-a-service (GBaaS) platform, plus cloud services. Third, it holds a large portfolio of equity-method investments, chiefly about 29% of Com2uS Corp (KOSDAQ 078340, developer of *Summoners War*) and 24.54% of Korean crypto exchange Coinone. It also sponsors the CONX (formerly XPLA) Layer-1 blockchain. Consolidated revenue is small at KRW 97.1 bn in FY2025, and the operating line has been loss-making since 4Q23 apart from 4Q25. Valuation is therefore driven far more by the look-through value of its investment stakes, its leverage, and new-game hit rates than by its operating earnings. --- **What the company does.** Com2uS Holdings describes itself in IR materials as a business-holding company with three operating pillars and one investment pillar: 1. **Game business (in-house publishing).** It sources, publishes and live-operates games globally. Some it develops itself. Most come from third-party or affiliated studios such as Com2uS, Second Dive, Ewie Games and NDEV Games. Revenue comes mainly from in-app purchases (free-to-play) on mobile, plus premium sales on Steam and consoles for its newer PC/console titles. Recent IR presentations describe four strategic genre axes for the game business: idle RPG, MMORPG/action, collectible RPG, and casual puzzle (BizWatch / Byline, 12 Aug 2026). 2. **Platform business (Com2uS Platform).** The subsidiary sells *Hive*, a game backend service covering authentication, payments, push, mailbox, coupons and analytics through one SDK and console. It is sold B2B to external developers. Com2uS Platform also resells cloud capacity, with Tencent Cloud as its core partner, and in 2025 began building industry solutions such as a next-generation web trading system for a securities firm (Toyo Economy, 12 Aug 2025). In September 2026 it launched *Hive Axyl*, an AI-agent-oriented version of Hive (iNews24, 30 Sep 2026). 3. **Blockchain business.** The company is a core partner and genesis contributor of the CONX mainnet (rebranded from XPLA in November 2025). It also runs the X-PLANET NFT marketplace and Web3 apps such as PLAY3 and Hello PAL. The post-rebrand strategy targets real-world-asset (RWA) tokenisation and security-token infrastructure rather than play-to-earn gaming (Bloomingbit; TokenPost, Nov 2025). 4. **Investment holding.** Its principal stakes are Com2uS Corp (≈29.4–29.5%, held with related parties) and Coinone (24.54% after the 2026 partial sale, including the stake held through subsidiary Com2uS Plus). Both are accounted for under the equity method. The company includes equity-method income and loss within consolidated operating revenue and operating profit. This is why consolidated operating profit swings sharply with Com2uS and Coinone results (Dealsite, 12 Aug 2026; BizWatch, 13 Feb 2025). **Revenue model mix.** No product/service/subscription/licensing split is disclosed. By characterisation, the parts are as follows. Game revenue is predominantly F2P in-app purchase, with a growing premium PC/console component. Hive is a usage- and contract-based B2B service. Cloud is resale and service revenue. Equity-method income is non-cash investment income. Dividends from Com2uS are booked as operating revenue at the standalone level. Gamevil added "investment business" to its articles in early 2020, and dividend income has been recognised as operating revenue since then (Dealsite, 9 Feb 2021). **Value-chain position.** The company sits mainly in publishing and live operations, the middle of the game value chain between studios and app stores and storefronts. It also sits in infrastructure through Hive and cloud, and in digital-asset infrastructure through its CONX and Coinone exposure. **Customer types and end-markets.** - B2C gamers worldwide. *Soul Strike* earned about 70% of its revenue overseas in 2Q25 (Co. IR, 12 Aug 2025). - B2B game developers and publishers through Hive. There were 137 contracted games and 100 client companies at 3Q25 (BizWatch, 11 Nov 2025). Hive has been applied to 250+ games with 980 m+ cumulative users as of September 2026 (iNews24, 30 Sep 2026). - Cloud customers, 52 as of end-July 2026 (BizWatch, 12 Aug 2026). - Financial and cultural-asset institutions, targeted by CONX's RWA/STO strategy. **Independent characterisation.** In economic substance, Com2uS Holdings is a leveraged, family-controlled holding company whose own operations are sub-scale relative to its balance sheet. Total assets were KRW 518.9 bn at FY2025, of which KRW 468.4 bn sat in long-term investments (S&P via StockAnalysis). Revenue in FY2025 was KRW 97.1 bn. The operating publishing business is hit-driven and has been cash-consuming: free cash flow was negative in each of FY2021–FY2025 per S&P data. Its distinctive assets are the Hive platform, the most credible scalable B2B asset, and the Coinone stake, which carries meaningful realisable value as the 2026 partial sale showed.

RevenueN/A
Employees144
Market CapN/A
Founded2000
United States, North America
Com2uS

Com2uS Corporation

Premium
Information Technology

Com2uS is one of Korea's original mobile-game companies and remains one of its most internationally exposed publishers. Its economics rest on two long-running franchises. The first is *Summoners War: Sky Arena* (launched 2014), a global collectible RPG with an esports circuit (SWC) and a revenue base that is mostly outside Korea. The second is a licensed baseball portfolio covering Korea's KBO, the US MLB and Japan's NPB, which crossed KRW 1 trillion in cumulative revenue in early 2026. From 2020 to 2023 the company expanded into film/drama production, K-pop, blockchain and the metaverse. That push produced record revenue but consolidated operating losses. Since 2024 it has been unwinding the diversification and refocusing on games under a finance-led CEO. In August 2026 the externally developed MMORPG *Zeus: God of Hubris* became its first major new hit in roughly 12 years. Com2uS trades below book value and pays a KRW 1,300 minimum dividend. --- ### What the company does Com2uS develops and publishes games, mainly for mobile with a growing share on PC and console. It sells them worldwide through the Google Play and Apple App Store marketplaces, its own PC launchers, Steam and Japanese PC platforms (DMM; Animate Games Online). Its self-description emphasises its pioneering history: first mobile game developer and service in Korea (1999), first Java game for mobile handsets worldwide (2000), entry into Japan in 2001, and local entities in China, Japan, the US and Taiwan. It reports serving games in about 160 countries [company profile, Jobplanet]. ### Business model and revenue model **Free-to-play live service with in-app purchases:** This is nearly all of game revenue. About 97% of game revenue comes from mobile [CB Insights summary of a Korean press report, Mar 2026]. The model depends on frequent content updates, seasonal events (baseball seasons, Summoners War anniversaries, year-end events) and IP collaborations. **Self-developed titles:** (Summoners War family, baseball series, *Tougen Anki: Crimson Inferno*, *Gachiakuta: BREAKOUT*, a Destiny Child IP game via Tikitaka Studio). **Third-party publishing:** (since 2024 an explicit pillar): *Zeus: God of Hubris* (Averton), *The Starlight* (Gametales), *Star Seed: Asnia Trigger* (Joycity), *Gods & Demons* (MOYE), an *Omniscient Reader's Viewpoint* game (Offbeat), *Project ES* (Averton). Publishing shifts part of the revenue to developers through revenue-share and royalty payments. Standalone royalty cost was KRW 11.3 bn in 2Q26 [Byline Network, 12 Aug 2026]. **Licensing out IP:** (Summoners War webtoon/animation projects) and licensing in IP (Kodansha, Shift Up, KBO/MLB/NPB player and league licences). **Media/content (subsidiaries):** Film/drama VFX and production, XR content and K-pop concerts/commerce. Following the July 2026 merger these sit in Com2uS N (formerly NP + Wysiwyg Studios) and MyMusicTaste. This activity is being scaled down [Dealsite, 2026]. ### Value-chain position Com2uS works across development, publishing, live operations, marketing and esports for its own IP. For licensed sports titles it is an exclusive licensee. Distribution depends on platform holders (Apple, Google), whose fees are the largest single cost line: standalone paid commissions were KRW 212.0 bn in FY2025, 39.6% of standalone revenue [CB Insights summary, Mar 2026]. Backend infrastructure (the "Hive" game platform) is run by Com2uS Platform, a subsidiary of the parent Com2uS Holdings and not of Com2uS itself [DigitalToday, Aug 2026]. ### Customers and end-markets The customers are consumers. The paying base is concentrated in North America, Korea, the rest of Asia (Japan, Taiwan, Southeast Asia) and Europe. The end-markets are global mobile gaming (core RPG, sports simulation and management), Korean MMORPGs, and Japanese anime-IP gaming, which the 2026–2028 pipeline targets. ### Independent characterisation Com2uS is a cash-generative but ageing two-franchise mobile publisher. Since 2020 its consolidated profitability has been weighed down by low-return M&A in media. Over 2021–2025 the standalone game business stayed profitable (standalone OP of KRW 21.0 bn in FY2023, 24.2 bn in FY2024 and 16.1 bn in FY2025). Consolidated OP was negative in FY2022–FY2023 and barely positive in FY2024–FY2025 because of subsidiary losses and write-downs. The 2024–2026 strategy has three parts: cut costs and subsidiaries, keep the two franchises running, and add new revenue streams through publishing and anime/webtoon IP. *Zeus* is the first clear result of the third part.

RevenueN/A
Employees1,453
Market CapN/A
Founded1998
United States, North America
Coloray

Coloray International Investment Co., Ltd.

Premium
Information Technology

Coloray International Investment is a Hong Kong holding company whose operating subsidiary, Zhejiang Coloray Technology Development, makes mica-based pearlescent (effect) pigments in Deqing, Zhejiang. Its core franchise is cosmetic-grade pearl pigments. Through ODM partners such as KOBO and Intercos, these reach color-cosmetics brands including Chanel, L'Oréal, Estée Lauder and Shiseido, and the company claims leadership in China's cosmetic pearl-pigment market. From 2015 to 2021 it was among the most profitable specialty-chemical names listed on KOSDAQ, with pigment operating margins of 54–61%. Since 2022 its profitability has collapsed. Gross margin fell from 64% (FY2021) to 22% (FY2025), and operating margin from about 52% to 0.5%, as it pushed into lower-margin industrial pearls, discounted to win share and absorbed a vertical-integration project in synthetic mica. The balance sheet holds about KRW 200 bn of cash and short-term investments against a market value of about KRW 25 bn. That gap is an extreme case of the "China discount" applied to PRC companies listed in Korea. --- ### What the company does Coloray designs, manufactures and sells pearlescent pigments, also called pearl-luster or effect pigments. These are platelet substrates, mainly natural or synthetic mica (fluorphlogopite), coated with thin layers of metal oxides such as titanium dioxide (anatase or rutile), tin dioxide, iron oxides and chromium-free colourants. Light interference in these layers produces luster, sparkle, colour-travel ("chameleon") and metallic effects. Coloray also produces mica powder and synthetic mica. It trades cosmetics and cosmetic pigments at wholesale and retail through its Korean and Hangzhou subsidiaries, and it conducts R&D in adjacent functional materials (S&P company description; Seoul Credit Rating & Information technology analysis report, 20 Jul 2026). The S&P description used by StockAnalysis and Simply Wall St summarises the business as follows: through its subsidiaries, the company manufactures, distributes and sells pearl pigments and mica powder in China; it also wholesales, retails and trades cosmetics and cosmetic pigments, and conducts R&D. The company's own positioning, from WiseReport's summary of the latest periodic report (Sep 2026), is a Hong Kong holding company established in 2013 whose actual operating subsidiary, Zhejiang Coloray, was founded in 2008. It maintains stable trading relationships with global cosmetics companies such as L'Oréal and Estée Lauder and is expanding global sales on the basis of high quality relative to price. ### Business model and revenue model | Revenue type | Share of revenue | Comment | |---|---|---| | Product sales: cosmetic pearlescent pigments | Majority (exact split not disclosed for FY2023–FY2025) | Historically the profit engine. Pigment operating margins were 57.7% (2018), 54.3% (2019) and 60.7% (2020) (Newstomato, Jan 2022). | | Product sales: industrial pearlescent pigments (coatings, plastics, inks, printing, leather, textiles, wallpaper, 3D-printing filaments) | Growing share since 2022 | Lower margin. Q1 2023 operating profit fell 55% YoY because of "lower margins on industrial products and discount promotions" (DealSite, 31 May 2023). | | Product sales: synthetic mica and mica powder (external sales) | Small; ramping since the 2024 plant completion | The chairman's 2023 plan was to sell about 2,400 t/yr of 6,000 t externally, generating about KRW 8 bn revenue (eToday, 29 Jun 2023). Actual external sales are not disclosed. | | Trading / distribution ("유통사업") | Material in 2020 (≈KRW 27–28 bn), sharply lower from 2021 | Luxury goods bought via Korean duty-free channels and resold on Chinese platforms (Tmall, JD.com, Pinduoduo). Distribution margin was about 6% (Asia Economy, 5 Jul 2022; Newstomato, Jan 2022). | | Services / subscription / licensing | None disclosed | 100% product and trading revenue | ### Value-chain position Coloray sits in the middle of the chain. Upstream are mica (natural flake from mining regions; synthetic mica from Chinese producers such as Crystal New Material and GNMI/Chesir), titanium tetrachloride/TiO₂ precursors and other metal salts. Coloray's process runs from grinding mica flake to powder, classifying it, wet-chemical coating, calcining, and surface treatment. Downstream customers are ODMs and OEM cosmetic manufacturers (KOBO, Intercos, Cosmax, Korea Kolmar), global and Chinese brands (L'Oréal, Estée Lauder, Chanel, Dior, Lancôme, Shiseido, P&G, Unilever, Perfect Diary), and industrial formulators of coatings, plastics and inks. Since mid-2024 the company has been integrating backwards into synthetic mica. The 6,000 t/yr synthetic mica base cost an investment of RMB 80 m (about KRW 14.3 bn) (DealSite, 22 Jun 2023; Asia Economy, 5 Jun 2024). ### Customer types and end-markets | End-market | Customer type | Named accounts (as reported) | |---|---|---| | Color cosmetics (eyeshadow, lipstick, highlighter, nail) | Global brands, cosmetic ODMs/OEMs, Chinese local brands | Chanel, MAC, L'Oréal, Estée Lauder (Edaily, Jul 2017); Dior, Lancôme, Unilever, P&G, KOBO, Intercos (DealSite, Jun 2023); Perfect Diary (Newstomato, Jan 2022); Cosmax (since 2016), Kolmar (from 2H 2017) | | Personal care (body wash, toothpaste, body cream) | Personal-care formulators | Demonstrated in finished applications at in-cosmetics Korea 2025 and 2026 (Asia Economy, 4 Jul 2025; 7 Jul 2026) | | Automotive and industrial coatings | Paint makers | Target market; synthetic-mica pearl for auto paint (DealSite, Jun 2023) | | Plastics and masterbatch | Plastics compounders, notably a European plastic-pearl opportunity | DealSite, Jun 2023 | | Printing inks and graphic arts | Ink makers | Coloray™ CR51xx/CR52xx series, Raystar™ Golden and Metallic Lustre series (UL Prospector) | | Leather, textiles, wallpaper | Industrial | UL Prospector; eToday, Jun 2023 | | 3D printing materials | Filament makers | "Stark Metal Series" exhibited at TCT Asia 2025 | ### Independent characterisation Coloray is a small Chinese specialty-chemicals company with a strong, high-margin niche franchise in cosmetic pearlescent pigments. Since 2021 that franchise has come under pressure from several directions at once: - weaker Chinese color-cosmetics demand after COVID; - aggressive capacity additions by domestic competitors, notably GNMI/Chesir and Kuncai; - its own decision to chase volume in lower-margin industrial grades and to discount. The holding-company structure, HK incorporation, PRC operations, KRW listing and a controlling founder together put it squarely in the "China discount" category on KOSDAQ. Its cash pile is several times its market value. Minority investors have historically had limited ability to see that cash returned to them.

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2008
Wan Chai, Hong Kong
Codes

Codes Combine Co., Ltd.

Premium
Information Technology

Codes Combine is a small, domestically focused Korean apparel company built around its namesake "Codes Combine" brand. The brand launched in 2002 as a women's young-casual label and was positioned in its 2000s heyday as a "Korean SPA" family brand. Today the company designs and sells women's apparel through department stores, agency stores, directly operated stores and wholesale clubs. It also generates smaller revenue from merchandise and an innerwear business, and it consolidates a real-estate subsidiary. Revenue has been flat at roughly KRW 38–42 bn a year since 2021. Operating margins compressed from 11% to 3% before recovering in FY2025 and 1H26. The equity story is dominated by its ownership structure rather than its operations. A single owner family controls about 60% through Co&Com and Cotton Club. The stock has a history of extreme low-float "품절주" (sold-out stock) squeezes and trades as an inter-Korean economic-cooperation theme stock. Related-party dealings are a recurring governance concern. --- ### What the company does Third-party descriptions drawn from company filings characterise the business as follows: - Simply Wall St (from S&P Global data) says the company manufactures and sells sewn garments in South Korea, sells design products, and rents out real estate. - Morningstar describes it as an apparel manufacturer whose main business is casual garments and underwear, with additional sales of office and "fancy" supplies, operating within Korea. - Asia Economy (Sept 2024) describes it as a women's apparel company whose flagship brand is Codes Combine, sold through department stores, agency stores and directly operated stores. - In 2024 management was moving the brand away from its young-casual image toward mainstream women's wear. It had hired specialists from established fashion companies and targeted KRW 45 bn of 2024 sales from about 60 stores. That target was missed: actual FY2024 revenue was KRW 39.6 bn. ### Company's own description The latest annual report (FY2025 business report, DART filing no. 20260318001354, filed 18 March 2026) is in Korean and could not be retrieved in full. Its verbatim business description is therefore not reproduced here. The latest disclosed revenue mix (2Q2026 basis, per Butler aggregating DART) is: - Fashion apparel: 77% - Merchandise (상품, goods purchased for resale): 12% - Underwear / innerwear: 11% ### Business model and revenue model | Dimension | Characterisation | Basis | |---|---|---| | Revenue model | Almost entirely product sales (apparel, innerwear, merchandise). Real-estate rental income comes via subsidiary CT&Combine. No subscription or licensing revenue disclosed | Butler segment mix; Simply Wall St; ETF Shopping | | Product vs service mix | Product ~100% of operating revenue; rental income is a minor consolidated item (amount not disclosed in retrieved sources) | Same | | Value-chain position | Brand owner / designer / wholesaler-retailer. Production is outsourced: Costco Korea product labels list Vietnamese contract manufacturer TAIHAN VINA Co., Ltd. as maker, with Codes Combine as importer | Costco Korea product pages (Jul 2026 manufacture date) | | Customer types | Retail consumers (women, broad age range); wholesale-club and online channel customers | Asia Economy 2024; Costco listings; StockHub | | End-market | Korean domestic apparel market, women's wear sub-segment | Morningstar ("functioned through Korea") | | Gross margin | About 51.6% (trailing twelve months to 30 Sep 2025: revenue KRW 38.7 bn, cost of revenue KRW 18.7 bn, gross profit KRW 20.0 bn) | Simply Wall St | ### Independent characterisation Codes Combine is a sub-scale domestic fashion brand, with about KRW 40 bn of revenue and fewer than 60 head-office employees. It operates in a structurally low-growth, highly competitive Korean apparel market. Its operations show: **Stable top line:** Revenue was KRW 38.3–42.0 bn in every year from FY2021 to FY2025. **Volatile profitability:** Operating margin fell from 11.2% in FY2021 to 2.8% in FY2024, recovered to 6.0% in FY2025, and reached about 13% in the 2026 interim period. **Heavy reliance on related parties:** These include the controlling family's Cotton Club group for real estate, historically for manufacturing (Cotton Club Vietnam makes Co&Com's innerwear), and for brand rights. The "Codes Combine Innerwear" trademark is owned by Co&Com, the controlling shareholder, not by the listed company. The market value of the stock is driven far more by thematic trading (low float, inter-Korean cooperation, "patriotic" substitution for Japanese brands) than by fundamentals.

Revenue$0.0B
Employees57
Market CapN/A
Founded1995
United States, North America
Quantapia

Quantapia Inc.

Premium
Information Technology

| Metric | FY2021 | FY2023 | FY2026 | |---|---|---|---| | Employees (headcount) | 26 | 36 | 5 | *FY2026 is the National Pension enrolment count from Saramin (Aug–Sep 2026), which is not directly comparable to filing headcounts.* Quantapia Inc., formerly Codenature and before that Ilkyung Industrial Development, is a micro-cap Korean holding-style operating company. It has spent most of its two decades moving between unrelated businesses. Those businesses include elevator guide rails, solar and wind EPC, cinema operation, cosmetics and health-food distribution, telecom services, melt-blown filter media, automotive bearing cages and, as a narrative only, quantum image sensors. It has reported a net loss every year since 2009, according to DRCR. It funded itself through repeated third-party rights issues and convertible bonds, and control changed hands at least six times between 2015 and 2025. Revenue fell from KRW 42.5bn in FY2019 to about KRW 3.8bn in FY2024. Its KOSDAQ listing ended in February 2025 after an SFC finding of fictitious FY2018 revenue. A criminal court acquitted the company on 11 July 2025 on statutory technical grounds. Third-party investors were convicted of manipulating its shares on 29 September 2026. It now appears to be a small distribution business with about five pension-enrolled staff. --- ### Company's own description Across its filings and summaries, the company has described itself in three different ways: **Codenature era (2019–2022):** Exchange-sourced company summaries (K5/KRX) describe a renewable-energy company (solar and wind) that also runs energy, distribution, telecommunications and mask-filter businesses. The corporate website lists four business areas: general product distribution, renewable energy, smart city, and telecommunication. **Quantapia era (2023–2025):** Korean Wikipedia, citing filings, describes a renewable-energy and quantum image sensor company. FnGuide's business summary headline attributes the revenue decline to stagnation in the solar market. **Current (2026):** NICE/Saramin data describe the business as domestic distribution of cosmetics, health functional foods and sportswear, under the "other household goods wholesale" industry code. Incruit lists "elevator rails and others", which reflects the legacy registered business purpose. JobKorea lists solar and renewable energy system design and sales. ### Independent characterisation On the evidence available, Quantapia is best understood as a listed shell that cycled through narrative businesses, not as an operating company with a durable franchise. Four features support this view: 1. **Revenue has collapsed and keeps changing composition.** Consolidated revenue was KRW 42.5bn in FY2019 and KRW 38.3bn in FY2020. FY2019 included solar EPC contract revenue, as shown by KRW 6.08bn of contract assets. By FY2022 revenue was KRW 4.36bn. 2. **Capital deployment went mainly to acquisitions, not operations.** DRCR calculates about KRW 77bn of net equity inflows and about KRW 19.5bn of net borrowing between 2006 and 2023. It reports that most of this went to equity investments rather than property, plant and equipment, while legacy real estate was sold off. 3. **Value-chain position.** In solar the company acted as an EPC contractor, buying modules and inverters and installing them. In distribution it was a brand-owner and wholesaler (the VIAMI cosmetics line). In bearing cages (via Hunus ENG) it was a Tier-2/3 component supplier. In MB filters (via K-Wave) it was a materials converter. 4. **Customers and end-markets.** The company served domestic solar project owners, consumer and retail channels, automotive and industrial bearing makers, and filter/mask producers. No customer concentration data were retrieved. ### Revenue model mix | Model | Business line | Period active | Status | |---|---|---|---| | Project/contract (EPC) | Solar and wind plant construction | c.2008–2022 | Diminished; H1 2022 parent EPC revenue KRW 0.68bn | | Product sales (wholesale/retail) | VIAMI cosmetics, M.SALT LACTO cleansers, health functional foods, sportswear | 2019–present | Appears to be the residual core business (2026) | | Product sales (B2B manufacturing) | Automotive/EV bearing cages (Hunus ENG) | Aug 2022–? | About 97% of Q1 2023 consolidated revenue | | Product sales (materials) | Biodegradable PLA melt-blown filter media (K-Wave) | Jun 2022–Mar 2024 | Divested Mar 2024 | | Services | Telecom business, smart city | 2019–2021 | Status not disclosed | | Licensing/subscription | None | — | — | | Narrative/development | Quantum image sensor (via Sandcraft relationship) | 2023–2024 | No revenue disclosed |

Revenue$0.0B
Employees5
Market CapN/A
Founded2004
United States, North America
Cntus-Sungjin

Cntus-Sungjin Co., Ltd.

Premium
Information Technology

CNTUS is a small-cap Korean maker of filtration media and filter products. It is built around meltblown (MB) polypropylene nonwoven technology that it describes as the first domestically developed MB media in Korea. The company spans the value chain from media extrusion to finished goods. Its core products are replacement filters for air purifiers (supplied to rental leaders such as Coway, SK Magic and Cuckoo), vacuum-cleaner and HEPA filters (Samsung, LG), automotive cabin filters (Kia), and KF-certified health and industrial masks under its own "Aer" brand. Production runs from Busan, Icheon, three Ulsan sites and a Vietnamese subsidiary. COVID-19 lifted revenue to a peak of KRW 170.9 bn in FY2021. Revenue has since fallen to KRW 67.2 bn (FY2025), and the company has posted operating losses. Management is diversifying into water filtration, Amazon-led US consumer sales ("Filteridge"), medical PLLA biomaterials, and since 2025 a Japanese-brand workwear retail platform ("Aer Works"). The balance sheet remains debt-free and liquid. The shares trade at roughly a quarter of book value. --- ### What the company does CNTUS manufactures and sells air filters and masks. Its April 2024 investor presentation describes the operating model as an "all-in-one" chain covering raw-material and media development, air and water filter production, and finished-product sales. Three business areas are named (CNTUS IR deck, Apr-2024): 1. **Air Solution (core).** Air purifier filters, vacuum-cleaner filters, automotive cabin filters, high-efficiency HEPA filters, and KF94/KF80 health masks and industrial masks. 2. **Water Solution.** Filter shower heads ("Quattro" filter shower), antibacterial sediment filters, carbon/UF filters, vitamin composite filters, water-purifier filters, positively charged (electropositive) filter media, and faucet/sink filters. 3. **Advanced/New Materials (Bio).** Flash-spun nonwovens, biodegradable bioplastic MB media and masks, and medical-grade PLLA (poly-L-lactic acid). A fourth activity was added in 2025. Through 100%-owned subsidiary AER Co., Ltd. (㈜아에르), the group operates Aer Works, a workwear platform and retail chain. It holds exclusive or priority Korean distribution rights for five Japanese workwear brands: Burtle, Xebec, TS Design, I'Z Frontier and Grace Engineer's (IB Tomato, 28-Jul-2026; Korea Times, 27-Nov-2025). ### Company's own description The company presents itself as a "Life Care Solution" company. Its stated ambition is to become the global No.1 in filters, with people-centred product design as its positioning (Hankyung Money interview with CEO Ha Choon-wook, Apr-2023, paraphrased). Data providers using its filings summarise the business as making air filters (air cleaner, vacuum, cabin and HVAC) plus disposable particulate masks, half-face respirators and particulate filters for industrial and consumer use (Simply Wall St; StockHub). ### Business and revenue model **Product sales, B2B-heavy:** Most filter revenue is OEM/ODM supply of replacement and line-fit filters to appliance makers and rental operators. Replacement demand recurs because purifier filters must be changed periodically under rental service schedules (CNTUS IR decks, Apr-2022 and Apr-2024). **B2C/D2C brand sales:** The Aer brand sells masks, filter showers, cabin filters and a "virus care" UV-C air steriliser through e-commerce (Coupang, Naver, Kakao) and the company's own mall ("The Aer"). Filteridge sells on Amazon US. **Retail and distribution (workwear):** Aer Works earns merchandise margin on imported Japanese workwear through company-operated stores. It plans franchising from 2027 (IB Tomato, 28-Jul-2026). **No subscription or licensing revenue:** is disclosed. **Segment reporting:** The company reports a single "manufacturing" segment, which accounts for 100% of revenue in Q2-2026 (Butler.works, from DART). ### Value-chain position CNTUS is vertically integrated upstream. It extrudes its own meltblown media in Busan, a capability it calls proprietary, and claims to have localised MB media in Korea first. It then converts media into finished filters and masks. This shields it partly from MB media shortages, which was decisive in 2020. It also means the company bears fixed-cost deleverage when volumes fall. ### Customer types and end-markets (CNTUS IR deck, Apr-2024) | Product family | Named customers / channels | End-market | |---|---|---| | Air purifier filters | Coway, SK Magic, Cuckoo Homesys, others | Home appliance rental and retail | | Vacuum-cleaner and cabin filters | Samsung Electronics, LG Electronics, Kia | Consumer electronics; automotive | | Health (KF) masks | Coupang, Naver, Kakao (e-commerce) | Consumer health | | Industrial masks | Daewoo Shipbuilding & Marine Engineering (now Hanwha Ocean), Hyundai Heavy Industries, Coupang | Industrial safety (shipbuilding, heavy industry, logistics) | | Workwear (Aer Works) | Industrial-site workers, B2B safety buyers, retail consumers | Occupational apparel | ### Independent characterisation CNTUS is a sub-scale, founder-controlled component supplier whose economics depend on a handful of Korean appliance OEMs and rental firms. The COVID mask windfall (FY2020–FY2021) left it with a large, mostly idle cash and securities position. Since FY2023 revenue has shrunk by more than half versus the peak. Management has spent cash on many adjacent bets (water, US e-commerce, PLLA, flash-spun nonwovens, workwear), and none yet offsets the decline in the core. The investment case rests more on balance-sheet value than on earnings power.

Revenue$0.0B
Employees144
Market CapN/A
Founded2003
United States, North America
CLIO

CLIO Cosmetics Co., Ltd.

Premium
Information Technology

CLIO Cosmetics is a mid-sized Korean beauty brand house. It is best known for color cosmetics: base makeup (cushions), eye products (palettes, liners, mascara) and lip tints. It runs a multi-brand portfolio. The flagships are CLIO and Peripera, supported by skincare (Goodal, Dermatory), hair care (Healing Bird), body care (TYPE No.) and a health-functional-food line (TRUERX). The model is asset-light: products are co-developed with Korean OEM/ODM manufacturers and sold mainly through third-party channels. Domestically the key channel is Olive Young (H&B), which provides roughly 56–60% of domestic sales. Overseas, sales go through Amazon and offline retail in Japan, North America, Greater China, Southeast Asia and Europe/Middle East. Revenue peaked at KRW 351.4bn in FY2024 and fell 6.4% in FY2025. A channel-rationalisation program in 2025–2026 lifted operating margin to a record 13.4% in 2Q FY2026, but top-line growth remains the open question for the equity story. --- ### What the company does CLIO designs, brands, markets and distributes cosmetics and personal-care products. Its business-purpose statement covers import/export of cosmetics and cosmetic tools and their sale and distribution (KIND quarterly report). It does not own large-scale manufacturing. Founder Han Hyun-ok built the company in the 1990s by co-developing color cosmetics with domestic OEM/ODM manufacturers. At that time, Korean color cosmetics relied heavily on overseas production (Ajou News, 2018). The FY2025 business report states that an internal brand organisation runs total brand management for CLIO, Peripera, Goodal, Healing Bird, Dermatory and other indie brands. This covers product planning, development, launch, branding, packaging and container design, store interior and channel-specific visual merchandising (KIND, FY2025 business report). ### Company's own characterisation In filings and IR materials, CLIO presents itself as Korea's representative color-cosmetics specialist. It traces its lineage to Clio Sangsa, which it describes as Korea's first domestic color-cosmetics brand house. Its long-running vision is "Every Pouch One CLIO": a CLIO product in every consumer's makeup pouch worldwide. Management keywords have rotated around customer experience, digital and global (2023), and customer perspective, global and digital innovation (2025) (eToday Jan 2023; TF Media May 2025; Jasoseol). ### Independent characterisation CLIO is best understood as a trend-driven brand-and-channel operator: **Value-chain position:** Mid-stream. It owns the brands, concept, formulation brief, design and go-to-market. Production is outsourced to ODMs. Logistics are being upgraded through a planned new logistics centre (EB proceeds, Jan 2026). **Revenue model:** Almost entirely product sales. There is no material subscription, licensing or service revenue. A small portion comes from B2B/vendor sales overseas, which declined 45% YoY in North America in 1Q FY2025 (Meritz). **Category mix:** Color cosmetics dominate. In FY2023 color was about 75% of revenue and skincare about 22% (eToday, Apr 2024). In 1Q FY2024 color was 78.1% and skincare 21.9% (Meritz). **Customer types:** End consumers, mainly women aged 10–30 (goinsider/DART summary). Sales go through retailers (Olive Young and other H&B stores, drugstores, variety shops, convenience stores), marketplaces (Amazon, Rakuten, Tmall, Douyin), home shopping, own e-commerce (Club Clio) and distributors. **End-markets:** Korea (about 53% of 2Q FY2026 sales) and overseas (about 47%). Overseas means Japan, North America, Greater China, Southeast Asia (Vietnam is about 60% of SEA sales), and Europe/Middle East/Africa (Kiwoom Jul 2025; eToday Aug 2026). ### Channel structure (Korea) | Channel | Role / latest data point | Source | |---|---|---| | H&B (Olive Young-led) | Largest channel. 1Q FY2024 H&B revenue KRW 28.4bn (+15% YoY), 50.5% of domestic sales. Olive Young is about 56–60% of domestic sales in 2026. H&B grew 24% YoY in 2Q FY2026 | Meritz (May 2024); Yuanta (Jul 2026); IBK (Sep 2026); Hyundai Motor Sec (Sep 2026) | | Online (own mall, vertical platforms, partner malls) | 1Q FY2024 KRW 20.8bn (+38%), 37.0% of domestic sales. Online +8% YoY in 2Q FY2026, led by vertical platforms | Meritz; Edaily (Sep 2026) | | Home shopping | Peaked at KRW 8.6bn in 1Q FY2024 (+115% YoY). Down to 7% of group sales by 4Q FY2025 (11% in 1Q FY2025). Live broadcasts ended in 2026, replaced by data broadcasting | Asiae (May 2024); SmartToday (Oct 2026) | | Duty-free | Being reduced as a high-commission channel | Meritz (Nov 2023); SmartToday (Oct 2026) | | Offline discount / convenience (Daiso; convenience "C" chain entry in 2025) | Daiso deliberately reduced in 2026 as low-margin | Meritz (May 2025); Hyundai Motor Sec (Sep 2026) | | Club Clio stores (own retail) | 95 stores at end-2016; cut to 77 by June 2020. Current count not publicly disclosed | Wikipedia; Dealsite (Jul 2020) |

Revenue$0.2B
Employees352
Market Cap$0.1B
Founded1993
United States, North America
Clientèle

Clientèle Limited

Premium
Information Technology

Clientèle is a mid-sized South African insurance group focused on the entry-level and lower-middle-income ("mass") market, where it sells simple, low-premium funeral, life, hospital, legal and savings products through direct and grassroots distribution: a large Independent Field Advertiser (IFA) network, telesales, agency kiosks, funeral-parlour intermediaries, a strategic affiliates channel and, since 2025, a micro-insurance adviser network serving social-grant recipients. Two acquisitions transformed its scale: 1Life Insurance (July 2024, settled in shares to Telesure Investment Holdings) and Emerald Life (June 2025, funded by R570m of preference shares). Group embedded value rose from R6.0bn (June 2024) to R10.3bn (December 2025). Persistently thin trading and a share price discount to embedded value led the board to take the company private via a company-funded offer at 85% of escalated embedded value (R19.90 per share), with delisting on 30 June 2026. The group remains controlled by a concentrated block of strategic shareholders. --- ### Company's own description In its regulatory and directory descriptions the company characterises Clientèle Limited as the holding company of the group whose long-term insurance subsidiary, Clientèle Life, markets, distributes and underwrites insurance and investment products and invests the funds derived from them, accounting for the majority of group earnings and assets; the group also offers personal and business-lines legal insurance through Clientèle General Insurance, its non-life subsidiary (Profile's Stock Exchange Handbook 2026 Issue 2). The IAR 2025 frames the group purpose as "Safeguarding Your World with Compassion" and the vision as becoming South Africa's most reliable and valued financial services partner. The chairman's stated long-run objective is a group product "in every home" (IAR 2025). ### Business model Clientèle earns money principally as a risk insurer of small-premium, long-duration retail policies (funeral, life, hospital cash-type, legal cover). The economics rest on: (i) high-volume, low-cost acquisition through community-based and direct channels; (ii) persistency — keeping premium-paying policies on the books for many years, since acquisition costs are front-loaded; (iii) claims experience; (iv) expense control; and (v) investment returns on policyholder and shareholder assets. The managing director's stated success drivers, reported in the IAR 2025, are exactly these: positive client contact, new business volume and quality, motivated employees, treating clients well, claims experience, persistency, expenses and investment returns. Supplementary earnings streams include: - **Single-premium investment business**, including co-branded single-premium investment products underwritten for Old Mutual and Absa clients (FY2024 results), which generate fee and spread income and drive large swings in financial assets. **Revenue from contracts with customers:** (R393.1m in FY2025): stand-alone Rewards (loyalty) contracts, IFA business-fee income, and deferred income on 1Life single-premium investment business. **Mobile services:** (Clientèle Mobile: SIM cards, data and airtime). ### Revenue model mix Clientèle does not report a product-vs-service-vs-subscription split. Using IFRS 17 line items for FY2025: insurance revenue net of reinsurance of c.R3,286m (IAR 2025 seven-year chart) versus revenue from contracts with customers of R393.1m (FY2025 results). On that basis roughly 89% of the two combined is insurance revenue and 11% is fee/rewards/service revenue (derived; not a company-defined metric). Premiums are overwhelmingly recurring monthly (subscription-like) collected by debit order, payroll deduction or SASSA grant deduction. ### Value-chain position Clientèle is vertically integrated: it designs products, distributes them through owned or contracted channels, underwrites the risk on its own licences (Clientèle Life, 1Life, Emerald Life, Clientèle General), administers policies and claims, and manages assets via an external investment manager under a group investment committee (IAR 2025). Emerald Life also administers and distributes policies underwritten by a third party, Lion of Africa Life Assurance (GroundUp, April 2026). 1Life historically relied on outsourced services from Telesure Group Services, which continued under amended agreements after the acquisition (1Life terms announcement, 3 November 2023). ### Customer types and end-markets - Low- and lower-middle-income South African households (LSM 1–8 per the group's consumer education reporting), largely black South Africans. **Social grant recipients:** (SASSA old-age pension and disability grant beneficiaries) — a core segment for Emerald Life and 1Life. **Government employees:** (Emerald Life). - Members of affiliated organisations and intermediaries (Strategic Affiliates Channel; funeral parlours). - Bank customers of co-branding partners (single-premium investments). - Small businesses (business-lines legal insurance). ### Independent characterisation Clientèle is best understood as a distribution-led mass-market risk insurer whose competitive moat is a low-cost, trust-based, community sales network rather than balance-sheet scale. Before 2024 it was a slow-growing, high-payout cash generator whose embedded value barely moved between FY2019 and FY2024 (R6.6bn to R6.0bn) because persistency pressure and debit-order disruption offset new business. The 1Life and Emerald deals nearly doubled embedded value and shifted the mix toward funeral micro-insurance for SASSA beneficiaries, a segment that is profitable but concentrated and politically sensitive. Post-delisting, it is effectively a privately controlled insurer with a minority of residual outside shareholders.

RevenueN/A
Employees3,663
Market CapN/A
Founded1993
United States, North America
CleenEnergy

Cleen Energy AG

Premium
Information Technology

CLEEN Energy AG was a Lower Austrian micro-cap that tried to turn a B2B energy-efficiency reseller into a vertically integrated solar platform. It started in 2014 selling and financing Philips-based LED retrofits to commercial customers. It then pivoted in 2020–2022 toward three things: - rooftop and ground-mounted photovoltaic (PV) installations for businesses; - an "energy-savings contracting" model in which it kept ownership of PV systems on clients' roofs and sold the power; - an ambition to own about 300 MWp of generation by 2024, with projects across Germany, Italy, Bulgaria, Croatia and Dubai. Rapid, debt- and equity-funded expansion collided with supply-chain margin compression, rising interest rates and weak governance controls. The result was successive restatements, a 2023 recapitalisation with a 5:3 reverse split, and finally insolvency in December 2024. At its peak (FY2022) the group generated EUR 12.8m in IFRS revenue but never produced a full-year operating profit. Its equity was negative in every consolidated balance sheet it published. --- ### The company's own description **FY2021 Annual Financial Report.** The group described itself as a leading Austrian full-service provider of sustainable, climate-friendly solutions in renewable generation and energy efficiency. It said its model let companies and public bodies realise renewable and efficiency projects without upfront financing costs. - The FY2021 portfolio was PV systems, power storage (including hydrogen), EV charging stations, heat pumps and LED retrofits. - The report claimed close to 2,000 customers: industrial and service companies, SMEs, agricultural operations and municipalities. **FY2024 Annual Financial Report.** The final report, written in the past tense after the bankruptcy, describes the group as having been an Austrian full-service provider of sustainable, climate-friendly solutions in renewable generation and energy efficiency. It also states that during the 2023–2024 restructuring the strategy narrowed to building and selling PV systems for third parties. ### Business model and revenue model | Model | Mechanics | Revenue recognition | Strategic role | |---|---|---|---| | Direct purchase ("Kauf") | Customer buys LED or PV equipment and installation outright. Larger projects bill in milestones: 10–50% on order, 10–30% at DC installation start, 10–30% at AC installation start, 10–20% on final invoice. | Point in time (customer acceptance or installation confirmation). For PV >100 kWp started after 1 Jan 2024: over time. | Became the dominant revenue source after 2023 | | Leasing | Third-party leasing (partners cited in data aggregators include UniCredit Leasing and Deutsche Leasing) | Point-in-time sale by CLEEN | Financing option | | Energy-savings contracting ("Einspar-Contracting") | CLEEN rents roof or land, plans, finances, builds, owns and operates the PV system for 20–40 years. The client buys self-consumed power at a monthly rate set below its prior power cost; surplus is fed into the grid. At contract end the client may take over the asset free or at a nominal value, extend, or have it dismantled. | Power revenue, point in time per delivery | Intended to create recurring "assets under management" revenue | | Revenue type (EUR k) | FY2023 | FY2024 | |---|---|---| | System sales (Anlagenverkäufe) | 9494 | 6787 | | Power sales (Stromerlöse) | 363 | 305 | | Other (mainly sale of a project right) | 1696 | 68 | | Total revenue | 11553 | 7160 | The company operated three commercial models, all documented in the FY2021 report and the FY2024 IFRS notes (revenue recognition, note 3.8K). **Revenue mix by type (FY2023–FY2024).** Source: FY2024 Annual Financial Report, IFRS note 5.1. In FY2024, product and installation sales were 94.8% of revenue and recurring power sales 4.3%. The contracting/IPP ambition therefore never became a material share of revenue. There was no subscription or licensing revenue. ### Value-chain position and customers **Value-chain position:** Downstream: project development, EPC (engineering, procurement and construction) and installation, financing structuring, and operation and maintenance (O&M). Asset ownership applied under contracting. **No manufacturing:** CLEEN sourced modules, inverters and LED fixtures from third parties. Novofuel GmbH, owned by core shareholder KawKaw Electronics International Limited, was a key module supplier (H1 2023 report). **Customer types:** Industrial companies, service firms, SMEs, agricultural businesses, municipalities and some private households (CLEEN zeero storage). **End-markets:** Commercial and industrial (C&I) rooftop solar, ground-mounted utility-scale development (Germany, Italy, Bulgaria, Croatia, UAE), commercial LED lighting, heat pumps, EV charging and behind-the-meter storage. **Customer concentration:** FY2024 had one customer above 10% of group revenue, with EUR 1.819m (25.4%). FY2023 had none. ### Independent characterisation Functionally, CLEEN was a regional C&I solar installer with an asset-light core and an asset-heavy aspiration. The contracting and IPP model required long-dated, cheap debt and patient equity. The company financed it with variable-rate bank loans (mostly 3-month EURIBOR, FY2021 report), shareholder loans and repeated small equity raises. When rates rose in 2022–2023 and module and logistics costs spiked, two problems compounded: - EPC margins collapsed: materials and purchased services reached about 87% of revenue in the FY2022 UGB preliminary figures, versus 75% in the prior year. - The ownership strategy became unfundable. The 2023 turnaround under new management was real at the contribution-margin level: H1 2024 contribution margin was EUR 1.529m, versus EUR -35k in H1 2023. But it came too late to service legacy debt, guarantees and accumulated losses.

Revenue$0.0B
Employees19
Market CapN/A
Founded2014
United States, North America
CXI

CXI Healthcare Technology Group Limited

Premium
Information Technology

CXI Healthcare Technology Group is a Cayman-incorporated holding company listed on KOSDAQ. Its operating businesses are in Fujian Province, China. It manufactures health supplements based on traditional Chinese medicine (TCM), sold as capsules, tablets, granules, drinks and teas, and distributes raw materials such as cordyceps, tea leaves and herbal inputs [S1][S37]. Since 2019 it has added a small cosmetics-distribution business, which brings Korean and Japanese skincare brands into China [S8][S15]. Earlier in its listed life the company reported revenue in the hundreds of billions of KRW. In FY2025 revenue fell to KRW 57.6 bn [S2], and recent quarters show gross losses [S27]. The balance sheet is large and almost debt-free (equity KRW 491.6 bn at June 2025) [S2], yet the market capitalisation is a small fraction of book value. In 2026 the company recapitalised under its CEO to stay listed under tighter KOSDAQ rules. In October 2026 it agreed to buy 55% of a Chinese enterprise-AI data company, which redirects the group toward AI services [S3][S5]. --- ### What the company does **Self-description.** In its filings and profiles, the group says it makes and sells health foods in China through subsidiaries. The products are TCM-based supplements in capsule, tablet, drink and tea formats [S1][S30]. A Korean-language profile derived from the company's disclosures adds three points [S37]: - the group runs a raw-material distribution business covering cordyceps and tea leaves; - the cosmetics unit sells TUNEMAKERS skincare through JD.com, Tmall Global and other major online platforms. Morningstar's profile states that all products are marketed only in China [S30]. **Independent characterisation.** CXI is a small, mostly domestic Chinese consumer-health company. Its listed shell has been used repeatedly for capital-structure transactions, and it is now being repositioned. Three features stand out: 1. **Operating shrinkage.** Revenue moved from the mid-2010s scale cited in Korean press to KRW 57.6 bn in FY2025 [S2]. It then fell to a run-rate below KRW 8 bn per quarter by the March 2026 quarter [S27]. 2. **Asset-heavy, cash-and-plantation balance sheet.** Total assets were KRW 575.2 bn at March 2026 [S26], against trailing revenue of KRW 51.4 bn [S25]. Depreciation and amortisation embedded in cost of sales was about KRW 24–26 bn per year [S25], which points to large plantation or land-use assets. 3. **Strategic pivot to AI.** The October 2026 decision to buy 55% of AIDT Technologies Limited [S3] would make AI data services the largest revenue line on consolidation. AIDT's H1 2026 revenue (USD 36.97 m, about KRW 53.6 bn) is larger than CXI's trailing twelve-month revenue [S3][S25]. ### Business model and revenue model | Revenue type | Description | Approximate weight | |---|---|---| | Product sales: health supplements | Own-manufactured TCM-based supplements (capsules, tablets, granules, drinks), sold to distributors and retailers | Not publicly disclosed (FY2025) | | Product sales: general foods / tea | Traditional teas, including Pu'er from an acquired plantation | Not publicly disclosed | | Distribution: raw materials | Trading of cordyceps, herbal inputs and tea leaves, at lower margin | Not publicly disclosed | | Distribution: cosmetics | Exclusive or general distribution of third-party brands (TUNEMAKERS, Answer Garden) and co-developed products | Not publicly disclosed; small | | Prospective: AI services (AIDT) | AI data collection and processing, data governance, model training and fine-tuning, industry AI applications | Not yet consolidated as of the decision date | There is no subscription or licensing revenue. The model is product and trading revenue. In 2012 management gave segment gross-margin guides of about 70% for health foods, 20–30% for distribution and about 50% for tea [S22]. Current segment margins are not disclosed. ### Value-chain position The group is vertically integrated from cultivation to branded product. It acquired a large Chinese-herbal plantation in 2015 [S16] and a Pu'er tea plantation in 2020 [S10]. It runs a tea-cultivation complex and a research lab [S8], manufactures in Fujian [S18], and sells through distributors and retail. In cosmetics it acts as a brand distributor or incubator, not a manufacturer [S7][S15]. ### Customers and end-markets **Channels (health foods):** Hypermarkets, supermarkets, pharmacies, health-food specialty stores and tea houses, mostly through wholesale or general distributors (총판) [S18]. **Channels (cosmetics):** JD.com, Taobao, Tmall Global and Xiaohongshu online. Offline, the business supplies franchise cosmetics retailers and agents. A Watsons China supply agreement was signed in October 2020 [S17]. **End-markets:** Chinese consumer health and wellness, Chinese tea, Chinese skincare and, prospectively, Chinese enterprise AI.

Revenue$0.0B
Employees378
Market CapN/A
Founded2009
United States, North America
CKDBio

CKD Bio Corp.

Premium
Information Technology

CKD Bio is the fermentation-API arm of the Chong Kun Dang group, one of Korea's largest pharmaceutical groups. It was carved out of Chong Kun Dang in 2001 and inherited a fermentation heritage dating to the 1960s, including Korea's first US FDA approval (chloramphenicol, 1968). Its core is a B2B, export-oriented portfolio of fermentation-derived antibiotics, β-lactamase inhibitors, immunosuppressants and antidiabetic APIs, made at a large Ansan plant approved by the FDA, AIFA, PMDA and TGA. Two newer businesses sit on top of this base: - a probiotics raw-material and CDMO business, historically anchored by supply to sister company Chong Kun Dang Health's Lactofit brand; - a botulinum toxin franchise, Tyemvers (CU-20101 / CKDB-501A), approved in Korea in March 2025, filed in China in August 2026, and in US neuropsychiatric development via partner Healis. The company is small (FY2025 revenue KRW 160.1B), thinly capitalised (market capitalisation about KRW 74B) and leveraged (net debt about KRW 141B). It sits in a margin squeeze between Indian and Chinese API price competition and an early-stage toxin ramp. --- **Company's own description.** The company describes itself as a developer and producer of high value-added products built on internationally competitive fermentation, synthesis and biotechnology capabilities, backed by continuous R&D (company "CKD BiO" overview page). It describes its Ansan plant in the Banwol industrial complex (51,473 m² site) as supplying the world with antibiotics, β-lactamase inhibitors, antidiabetics and immunosuppressants. The FY2025 annual report summary on FinancialFilings characterises it as a pharmaceutical company specialising in fermentation and chemical synthesis that also produces next-generation probiotics using patented technology. **What it actually does.** CKD Bio runs four economic activities: 1. **Fermentation and semi-synthetic APIs and intermediates (core; about 83–86% of revenue).** Bulk drug substances sold to generic and originator manufacturers worldwide. Key molecules include: - potassium clavulanate (β-lactamase inhibitor); - rifampicin and rifamycin sodium (anti-tuberculosis); - teicoplanin (glycopeptide antibiotic); - demeclocycline HCl (DMCT); - acarbose (antidiabetic); - cyclosporine, tacrolimus and everolimus (immunosuppressants); - diquafosol sodium (dry-eye). The company also sells API trading, contract research and contract manufacturing services (product pages, 2026). In 1Q2025, APIs were 85.9% of revenue (KRW 36.5B), and antibiotics alone were 62.1% (KRW 26.4B) (Nate/Bio report, Apr-2026). 2. **Probiotics (about 13–14% of revenue).** Production of probiotic "raw powder" (원말) and finished products. The catalogue lists 25 strains/items, including *S. thermophilus*, *L. bulgaricus*, *L. rhamnosus*, *L. reuteri*, *B. breve* and *B. longum*, at concentrations up to 5×10¹¹ CFU/g (product page). A major historic customer is related party Chong Kun Dang Health (Lactofit). The company also offers microbiome CDMO services. 3. **Botulinum toxin type A (about 2% of revenue in 2025–1H2026).** Tyemvers 100U, launched in Korea on 21–22 July 2025, with a 200U presentation launched in August 2026. Out-licensing economics come from Cutia Therapeutics (Greater China) and a supply arrangement with Healis Therapeutics (US neuropsychiatry). 4. **Contract manufacturing / CDMO.** Offered for APIs, intermediates and microbiome products using cGMP fermentation and synthesis assets (company home page). **Revenue model.** Revenue is predominantly product sales: - B2B bulk API shipments, priced per kilogram under supply contracts and spot orders; - B2B probiotic powders; - B2C/B2B toxin vials sold to Korean clinics through the company's own sales organisation. There is small licence and milestone income from toxin partners. For example, the FY2022 toxin-segment revenue of KRW 6.0B is consistent with the Cutia upfront payment plus the China IND milestone (US$2.0M + US$2.5M). There is no subscription revenue. **Value-chain position.** Upstream manufacturer of drug substances, sitting between raw-material and nutrient suppliers and finished-dosage formulators. In toxin, the company is vertically integrated from strain to vial. **Customer types and end-markets.** - Generic and originator drug makers in the US, EU, Japan, emerging markets and Korea. Exports were 79.0% of revenue in 1Q2025 (Medigate, Jun-2025). - Health-functional-food brand owners. - Korean dermatology and plastic-surgery clinics (toxin). - Licensees (Cutia, Healis). **Independent characterisation.** CKD Bio is a sub-scale, legacy fermentation-API exporter trying to buy a growth option (toxin) with a balance sheet that has little room for error. The API base provides volume and GMP credibility but is structurally exposed to Indian and Chinese pricing (Kormedi, Apr-2026). Group affiliation (Chong Kun Dang Holdings 39%) provides financing comfort and related-party demand (probiotics), but also governance overlap. The toxin business is differentiated on paper: - human-serum-albumin-free (vegan) formulation; - GenBank-registered strain of German/European origin; - first halal certificate (BPJPH) for a botulinum toxin. However, it entered as Korea's sixth domestic toxin into a crowded, price-competitive market.

Revenue$0.1B
Employees530
Market CapN/A
Founded2001
United States, North America
City

City Lodge Hotels Limited

Premium
Information Technology

City Lodge Hotels is South Africa's pioneer and leading pure-play operator of "select-service" hotels. It focuses on clean, safe, well-located and reasonably priced rooms rather than resort amenities. It owns or leases and self-operates a portfolio of roughly 56 hotels across four tiered brands, from economy Road Lodge to upscale Courtyard Hotel. The portfolio is concentrated in South African metropolitan business nodes, with a small Southern African Development Community (SADC) footprint in Botswana, Namibia and Mozambique. The group has come through the Covid-19 collapse by: - raising R1.2 billion of equity; - exiting loss-making East Africa; - deleveraging to a near-zero bank-debt position; - rebuilding margins to roughly 30% (adjusted EBITDAR). Its current strategy has four strands: - refurbishing ageing hotels to a "new generation" brand standard; - growing food and beverage (now about 20% of revenue); - investing in energy and water resilience against municipal failures; - returning capital through dividends and sizeable buybacks. It is a small-cap, domestically exposed, cyclical equity. It trades at roughly 11x trailing earnings and 5.8x EV/EBITDA (S&P). --- ### What the company does City Lodge Hotels owns, leases and operates limited-service and select-service hotels. Its directors' report (FY2023 AFS) describes the group as owning and operating high-quality, affordable hotels aimed at the business community and leisure travellers. The FY2026 investor communication describes its four brands on an "easy" theme: - Courtyard Hotels as upscale ("the soft life made easy"); - City Lodge Hotels as upper midscale ("easy living"); - Town Lodges as "the easy choice"; - Road Lodges as economy, "basically easy" accommodation. The corporate brand slogan introduced in FY2024 is "Life is hard. Check into easy." ### Business model The group is an owner-operator, not an asset-light franchisor. It does not franchise or manage hotels for third parties, based on all disclosures reviewed. Its real-estate base is a mix of: **Freehold property:** land and buildings at cost of R144.5m and R1.80bn respectively in the FY2023 AFS. **Long-term land-and-building leases:** recognised under IFRS 16. - Right-of-use assets were R1.01bn at FY2023. - Lease liabilities were about R1.44bn at FY2025. - Lease tenors run from 2 to 30 years, with up to five renewal options. - Example: City Lodge Hotel Waterfall City and Courtyard Hotel Waterfall City are leased from Attacq/Barrow under land-and-building leases. The group bears full operating leverage. Revenue depends on occupancy and average room rate (ARR). A large fixed-cost base (salaries, property costs, lease costs) means small changes in occupancy drive large changes in earnings. ### Revenue model | Stream | Recognition | FY2026 share (derived) | |---|---|---| | Accommodation (rooms) | Point in time, when the stay is consumed | ~79% (R1.74bn of ~R2.2bn) | | Food and beverage (F&B) | Point in time, on delivery | 20.4% (R449.9m) | | Other revenue (conferencing, ancillary services) | Point in time, on completion | <1% | Revenue falls into three IFRS 15 streams, per the FY2023 accounting policies: There is no subscription or licensing revenue. A customer loyalty programme defers part of the consideration as a contract liability; points expire after three years (FY2023 AFS). Revenue is 100% service revenue. ### Value chain position City Lodge sits at the operator/owner layer of the lodging value chain. It sells through three routes: **Direct channels:** its own website (relaunched in FY2025), a call centre, and a "Best Available Rate" dynamic pricing strategy adopted during Covid. **Corporate and government contracted rates:** - Third-party channels: online travel agencies, travel management companies and tour operators. FY2026 room-related costs rose 11%, partly because of higher commissions on extra corporate and government sales. It procures food, linen, utilities and maintenance services. It has invested heavily in self-generation (solar at 40 hotels) and water self-sufficiency (boreholes and filtration at 14 hotels) to reduce dependence on failing municipal supply. ### Customer types and end-markets | Segment | Characteristics | Evidence | |---|---|---| | Domestic corporate and business travellers | Core, midweek demand; historically the founding market | FY2026: good midweek demand offset weak weekends | | Government and public sector | Contracted rates; commission-bearing | FY2026 room costs rose with extra government sales | | Domestic leisure | Weekends and holidays; price-sensitive | FY2026 Q4: weekend and leisure stays especially weak after fuel-price spikes | | International inbound leisure | Concentrated in the Western Cape; currency-advantaged | FY2026: Western Cape revenue +21% on international travel | | Events and conference-driven demand (MICE) | Episodic | FY2026 H1: B20/G20 tailwinds | | SADC cross-border business | Botswana, Namibia, Mozambique | Mozambique revenue up more than 20% in FY2026 | ### Independent characterisation City Lodge is effectively a levered bet on South African domestic business-travel volumes. It has a defensible niche in the three-star and below select-service tier, where it has the largest dedicated branded portfolio in South Africa. Its competitive edge rests on: - brand recognition built over 40 years; - prime urban and airport locations; - a lean operating model with no heavy F&B, spa or casino overheads. The post-Covid strategy has shifted the model in three ways: 1. A greater F&B share: from 15% of revenue in FY2022 to 20.4% in FY2026. 2. Capital recycling: selling or exiting loss-makers, namely East Africa, Katherine Street, Courtyard Arcadia and City Lodge Newtown. 3. A capital-return orientation: buybacks of about 6.4% of shares in FY2026 alone. The main structural weaknesses are: - high IFRS 16 lease intensity, with lease liabilities more than the market capitalisation's half and about 1.2x equity; - dependence on fragile municipal infrastructure; - a weak domestic economy that limits pricing power.

Revenue$0.1B
Employees1,213
Market CapN/A
Founded1985
United States, North America
CITECH

CITECH Co., Ltd.

Premium
Information Technology

CITECH is a small-cap Korean holding-and-operating company, with a market value of about KRW 36 bn. Its roots go back to a 1967 incorporation. Today it runs four product franchises that share little operationally. The first is unattended kiosks and automatic certificate and ticket issuers for Korean public-sector buyers such as municipalities and Korail. The second is HiFi Rose, a premium network-audio brand sold mostly abroad. The third is MOD, a smart hospital-bed platform serving about 40,000 beds in Korea. The fourth is a public-address/broadcast business added through the KEVIC merger. Management presents CITECH as an "AI convergence solutions company," with AI healthcare as the stated growth pillar. The FY2025 return to operating profit was modest (KRW 2.0 bn), and reported net profit was dominated by non-operating gains. In 2026, revenue fell more than 50% year on year in 1Q and 2Q. A shareholder with 19.5% is contesting control with the CNC Technology group, and the company completed a share consolidation. The equity trades at about 0.5x book. --- ### Company self-description In its 2025–2026 communications, CITECH describes itself as an AI-healthcare and audio-platform company. Its stated aim is to become an "AI convergence solutions company" by combining its existing businesses (audio, kiosks) with hospital-infrastructure capability absorbed through the MOD merger and new AI products (company statements carried by Finance Scope and Asia Economy, 24 Mar 2026). A Google Finance profile, drawn from Wikipedia, lists four business divisions: AI Healthcare, Media, MoD, and PA Solution. Morningstar's legacy description is narrower: automatic document issuers and kiosk systems, covering certificate and ticket issuance, kiosk management, order management, digital information displays (DID) and "smartcare" systems. ### Independent characterization CITECH is best understood as a Korean small-cap with a portfolio of niche hardware-plus-software businesses and a large investment/holding component: 1. **Kiosk & unattended issuance (legacy core).** The company designs and manufactures unattended civil-document issuers (for example the CI-9000H), ticket vending machines (the Korail new-generation machine tender, Oct 2024), hospital reception and prescription kiosks, and library management systems. Demand is driven mainly by Korean public procurement and accessibility mandates. From 28 January 2024, public institutions must buy accessibility-compliant kiosks (MT/The Bell, 10 Oct 2024). 2. **HiFi Rose (premium consumer audio).** This is an in-house brand of touchscreen network streamers, DACs and amplifiers running the proprietary Rose OS. It is export-oriented: 87% of 2024 HiFi Rose sales were exports, as cited from company material by MadeGoodDesigns. Products are sold in roughly 40–45 countries (FnGuide; MT, 15 Jan 2026). European distribution runs through a 50%-owned JV with Swiss loudspeaker maker PIEGA. 3. **MOD (smart hospital beds / "AI Healthcare").** MOD was absorbed by merger in 2025. It supplies bedside multimedia terminals, smart-TV services and nurse-call systems. The company says it serves about 40,000 hospital beds nationally and has supplied bed TVs to about 300 hospitals (Finance Scope / MTN, 12 Oct 2026; Industry Daily, 21 Mar 2026). 4. **PA Solution (public address / broadcast audio).** This started as a new PA division with first revenue in FY2025. It was enlarged by absorbing subsidiary KEVIC, which has about 30 years of history in broadcast/PA audio and sells through Korea's public e-procurement channel (Nara Marketplace). The merger was effective 1 April 2026. 5. **Investment holdings.** CITECH's most valuable asset may be its equity stake in KOSDAQ-listed AnRobotics (formerly Hyupjin, 138360), where CITECH and related parties are the largest shareholder. CITECH also holds associate stakes in Sungbo Industry, iFriend and Taeyoung M&F. ### Revenue model and value-chain position **Revenue mix by model:** Mainly one-off product sales (kiosks, audio hardware, PA equipment, bedside terminals). Recurring elements include service and maintenance (MOD smart-bed service and after-sales; the bedside business requires periodic inspection and A/S per MTN, 12 Oct 2026) and leasing/distribution income. CITECH does not disclose a product/service/subscription split. → *Exact split: not publicly disclosed.* **Value-chain position:** CITECH is an integrated designer and assembler. HiFi Rose products are assembled in Korea (StereoNET). The KEVIC merger was explicitly framed as vertical integration of R&D, manufacturing and sales (MT, 15 Jan 2026). **Customer types:** Korean central and local government, public agencies and Korail; hospitals and medical foundations; audiophile consumers through distributors and dealers (e.g., Henley Audio UK, ROSE x PIEGA in Europe, Music Direct US). **End-markets:** public-sector IT/kiosks; healthcare IT; premium consumer audio; commercial/public broadcast audio.

Revenue$0.0B
Employees78
Market CapN/A
Founded1967
United States, North America
Chunbo

Chunbo Co., Ltd.

Premium
Information Technology

Chunbo is a Korean fine-chemical synthesis and purification company. It has moved from niche display and semiconductor process chemicals to specialty lithium salts and electrolyte additives for lithium-ion batteries. Its main technical claim is that it was the first company worldwide to commercialize LiFSI (the "F-electrolyte"). Sources date this to 2016 or 2017. It also makes LiPO2F2 (the "P-electrolyte"), on which Korean battery-cell export volumes have tracked its revenue closely, together with LiDFOP, LiBOB and a broad range of film-forming additives (VC, FEC, PS, ESA and others). A smaller electronic-materials franchise (LCD etchant additives, OLED common-layer materials, semiconductor process chemicals, oxalic acid) supplies most of the operating profit at around 20% margins. Since 2021 the company has spent heavily on a greenfield LiFSI and additive complex in Saemangeum through subsidiary Chunbo BLS, financed largely with mezzanine capital. The 2023–2025 downturn in electrolyte prices, combined with plant delays, eliminated profits. The 2026 investment case depends on ramping LiFSI supply to a North American OEM's 4680 cell program and on a recovery in Chinese electrolyte demand. --- ### What the company does Chunbo is a specialty-chemical manufacturer working in three technology domains that its IR material calls IT, BT and GT. In its own descriptions it supplies: - additives used in manufacturing LCD and OLED display panels; - raw materials for EMC (epoxy molding compound) resins; - semiconductor process materials; - oxalic acid; - pharmaceutical raw materials and intermediates; - secondary-battery materials (lithium salts and electrolyte additives); - other specialty chemicals, including tire additives and materials for chemically strengthened display glass. Source: company description as summarized by StockHub and Kiwoom (2026); Chunbo IR decks 2022–2024. The company describes itself as a "comprehensive precision chemical materials company." In a 2023 investor meeting, its CFO said the company's real identity is fine chemicals: it is strong in synthesis and purification, it often holds first-mover or near-monopoly positions in the molecules it makes, and its products have historically carried market shares near 90% with operating margins near 20% (Digital Daily, 30 Apr 2023). Third-party profiles also call Chunbo Korea's only oxalic-acid producer, supplying Korean chipmakers and exporting to Japan and Taiwan, and the world's largest producer of 5-aminotetrazole (ATZ) (Innoforest company profile). ### Business model and revenue model The revenue model is product-based and B2B: it sells high-purity chemicals by weight under supply agreements. There is no material service, subscription or licensing revenue disclosed. Key features: **Battery materials (~51–58% of revenue):** Lithium salts and additives are sold to electrolyte makers and battery-cell makers. Pricing is linked partly to lithium carbonate and LiPF6 market prices, which caused the 2023–2024 collapse in average selling prices. Broker research in late 2025 and 2026 points to price pass-through clauses: Mirae Asset expected roughly 20% pass-through of raw-material increases into selling prices from H2 2026 (Mirae Asset via HelloT, 13 Apr 2026). **Electronic materials (~29–38%):** Etchant additives, OLED intermediates and semiconductor chemicals are qualified into specific customer processes. This creates high switching costs and stable margins; Mirae Asset cites operating margins around 20% (Apr 2026). **Pharma intermediates, fine chemicals and other (~8–13%):** Custom synthesis and catalog chemicals, including ATZ and oxalic acid. ### Value-chain position In the battery chain, Chunbo sits upstream of electrolyte formulators (e.g., Dongwha Electrolyte, Enchem, Soulbrain, and Chinese formulators) and battery-cell makers. It supplies the functional salts and additives, typically a few percent of electrolyte weight, that set cycle life, high-voltage stability, low-temperature performance and safety. LiFSI can also be used as a co-salt alongside, or partial replacement for, LiPF6. In display and semiconductor chains it is a tier-2 or tier-3 chemical supplier to panel makers, chemical formulators and fabs. ### Customer types and end-markets | End-market | Customer types | Named customers (as disclosed or reported) | Source | |---|---|---|---| | EV and ESS batteries | Cell makers; electrolyte formulators | LG Energy Solution, Samsung SDI, SK On, CATL, BYD, Panasonic, Tesla | CFO remarks, Digital Daily (30 Apr 2023) | | EV batteries (2020-era) | Cell makers | LGES, Samsung SDI, SK Innovation, CATL; the batteries went into BMW i3/i8, Chevrolet Volt, VW e-Golf | TheElec (25 Jan 2021) | | China (2025–26) | Cell makers | EVE Energy (LiPO2F2 volume growth in Q4 2025) | Kiwoom (2 Jan 2026) | | North American OEM | OEM in-house cell production | F-electrolyte shipments since early 2026, believed by Mirae Asset to go to Tesla's 4680 cells for the Cybercab | Mirae Asset via HelloT (13 Apr 2026); Kiwoom (27 Aug 2026) | | Display | Panel makers and etchant formulators | Not named in sources | — | | Semiconductors | Korean chipmakers (oxalic acid, process chemicals) | Not named | Innoforest | | Pharma | Pharmaceutical companies | Not named | StockHub/company description | ### Independent characterization Chunbo is a capable small-molecule chemist that made a large, debt-financed bet on a single application. Battery materials grew from about KRW 2bn of revenue in 2015 (Hana Financial Investment, cited by Asia Economy, Oct 2018) to around 68% of group revenue by 2022 (Dealsite, 25 Apr 2023). That transformed Chunbo from a steady mid-teens-margin specialty house into a cyclical, capital-intensive battery-materials company. Three things then went wrong at once: the 2023–2024 lithium price collapse, Chinese overcapacity in LiFSI and additives, and delays at the Saemangeum plant. Together they turned an operating margin of 17–19% (FY2021–FY2022) into losses (FY2023–FY2024). Since 2025 the business has returned to marginal operating breakeven. Net losses continue, driven by non-cash derivative losses on convertible bonds and by interest. The electronic-materials franchise is the stable core that partly subsidizes the battery ramp.

Revenue$0.1B
EmployeesN/A
Market CapN/A
Founded1997
Chungju, South Korea
SailMining

Sail Mining Group Limited

Premium
Information Technology

Sail Mining Group Limited, formerly Chrometco, is a small, majority-controlled South African chrome producer listed on the JSE AltX. Its economic exposure runs mainly through a controlled interest in Black Chrome Mine (Pty) Ltd, an underground chrome operation on the eastern limb of the Bushveld Complex in Limpopo, and an associated chrome processing plant. From FY2019 to FY2021 the group generated R1.1–1.4 billion of annual revenue, almost entirely from exporting chrome ore and concentrate through a Singapore-based affiliate of its controlling shareholder. It never reported a full-year profit in that period. Covid-19 disruption, high logistics costs, weak chrome prices, a breached trade-finance facility and distress across the wider Sail group led to care and maintenance at Black Chrome in mid-2021. The mine entered business rescue in June 2022, and the shares were suspended in July 2022. Black Chrome exited business rescue in December 2024 under a "Mine Restart and Trade Out Plan". The board now proposes to delist via a 7.2c-per-share repurchase. The equity is best understood as a controlled holding company with a minority exit pending. --- ### Company's own description In its last published annual results (FY2021), the company describes itself as a mining and exploration group focused on chrome mining and processing in South Africa. The FY2020 results used near-identical language, referring to chrome mining and beneficiation. The 2011 Rooderand circular announcement records the original mandate. At its 2005 listing, Chrometco was a chrome exploration company. It intended to explore and, if viable, develop a chrome mine, and also to investigate other chrome and base-metal properties and opportunities in mining, concentrating and beneficiating ferrous metals (chrome, copper, cobalt, nickel and manganese). Third-party profiles (Investing.com, Simply Wall St) describe a mineral exploration and mining company with interests in chrome, platinum, copper, cobalt, nickel and manganese. According to the Investing.com profile, the company operates the chrome processing plant and manages export logistics through its subsidiary Sail Minerals (Pty) Ltd. The same profile says Black Chrome Mine (Pty) Ltd, which owns the mining right, is controlled through a 51% interest in Sail Resources (Pty) Ltd, which in turn owns 64% of Black Chrome Mine. ### Independent characterisation **Business model.** In practice, the company is a single-asset, upstream chrome producer whose route to market is captive. Run-of-mine chrome ore from Black Chrome Mine (BCM) is either sold as lower-grade ore or upgraded in the group's chrome processing plant into metallurgical-grade chrome concentrate. The phases of the plant were commissioned between November 2019 and late FY2021. The plant also produces a PGM-bearing "intermediate product", which is sold locally to a PGM producer. **Revenue model.** Revenue is 100% product sales. There is no service, subscription or licensing revenue. **Customer concentration.** This is extreme. In FY2019 and FY2020, all export revenue was booked as sales to Sail International Marketing Pte Ltd (SIM), a related party formerly called BBA Resources Pte Ltd. In FY2021, sales to SIM were R1,225.0 million, or 86.1% of group revenue (computed). **Value-chain position.** Upstream extraction and primary beneficiation (concentrating). The company has no ferrochrome smelting. End-use exposure is indirect: about 95% of chrome ore globally goes into ferrochrome and then stainless steel, mostly in China (Engineering News, July 2026). Company disclosures in 2020 explicitly link chrome exports to Chinese demand. **Customer types and end-markets.** The intermediate customer is a related-party trader. Final demand comes from Chinese ferrochrome and stainless-steel producers. The PGM intermediate product goes to a domestic PGM producer under a life-of-mine offtake agreed after FY2021 year-end; the counterparty was not named. **Financing model.** Operations depended on related-party funding (Sail group payables, a R230 million subordinated SIM balance), an ABSA structured trade-finance facility secured on exported chrome, and finance leases for mining equipment and a Volvo mining fleet. **Current operating state (2025–2026).** Black Chrome exited business rescue in December 2024. The company's September 2025 update describes the BRP's restart plan as restructuring BCM into an integrated chrome producer and processor following a low-cost, low-risk strategy. No production, revenue or cash-flow data for the restarted operation has been published.

Revenue$0.1B
EmployeesN/A
Market CapN/A
Founded2002
Sunninghill, South Africa
Chorokbaem

Chorokbaem Media Co., Ltd.

Premium
Information Technology

| Item | Detail | |---|---| | Legal name (Korean) | (주)초록뱀미디어 | | Legal name (English) | CHOROKBAEM MEDIA CO., LTD. ("Chorokbaem" literally means "green snake") | | Former names | Konictech Co., Ltd. (코닉테크); renamed Chorokbaem Media in 2005 after a reverse-merger / backdoor listing of the drama producer Chorokbaem M&C (Simply Wall St / Yahoo Finance profile; eToday 2013) | | Founding | Listed shell: incorporated 26 May 1998 (corporate registry via Bolta / ETF Shopping). Operating drama business: Chorokbaem M&C, founded in 2000 by former SBS drama producer Kim Ki-beom (Yuanta report, Mar 2021) | | Incorporation jurisdiction | Republic of Korea; corporate registration no. 110111-1549786; business registration no. 220-81-52270 | | Headquarters (current) | 16F Doosan Building, 726 Eonju-ro, Gangnam-gu, Seoul 06057 (FY2025 business report via ETF Shopping; National Tax Service status check, Oct 2026) | | Prior HQ addresses in public databases | 14F Hanseong Cheongdam Bldg, 414 Dosan-daero, Gangnam-gu (Yahoo Finance profile); 310 Bongeunsa-ro, Gangnam-gu (Wikipedia, older data) | | Exchange / ticker | KOSDAQ (Korea Exchange): 047820 (Yahoo: 047820.KQ). KOSDAQ listing date of the listed entity: 24 December 2002 (Digital Today, Feb 2026) | | ISIN / CUSIP | No CUSIP: the shares are not US-listed | | Shares outstanding | 24,453,930 common shares (DART ownership reports, Sep–Oct 2025; ETF Shopping FY2025: 24.45M). A 10:1 share consolidation (par value KRW 500 → 5,000) was approved in 2022 (eToday, Mar 2022) | | Fiscal year end | 31 December | | Employees (standalone, DART) | 2021: 29 · 2022: 50 · 2023: 45 · 2024: 41 · 2025: 43 (ETF Shopping, from DART business reports). National Pension enrolment: 49 (Oct 2026, Bolta). Group headcount including subsidiaries: not publicly disclosed | | Representative directors | Kim Dong-jun and Yoon Dong-hyun (co-CEOs, each with independent authority), both from Q Capital Partners | | Controlling shareholder | QCP Media Holdings LLC (vehicle of Q Capital Partners' "2021 QCP No.15" PEF). 45.04% of common shares at FY2025 year-end. 52.41% (12,817,045 shares) at end-H1 2026 (IB Tomato, Sep 2026). 65.4% on a "specified securities" basis including convertible bonds (large-holding report, 19 May 2026) | | External auditor | Not publicly disclosed in sources reviewed | | Market capitalisation | KRW 73.9 bn at a closing price of KRW 3,020 on 19 Oct 2026 (ETF Shopping) | | Website | www.chorokbaem.com | | Industry classification | Broadcast programme production (KSIC 59114) | It has not been renamed or relisted since the ticker was assigned, so no substitution was made. Chorokbaem Media is a mid-sized, Seoul-based Korean drama producer with a 25-year catalogue that includes *All In*, *Phoenix*, *Jumong*, *Chuno*, the *High Kick* sitcoms, *My Mister*, *The Penthouse*, *My Liberation Notes* and *The Escape of the Seven*. Its writer relationships with Park Hae-young, Kim Soon-ok, Lim Sung-han and Moon Young-nam are its main competitive asset. From 2020 to 2023 its former controlling family used acquisitions and mezzanine financing to turn it into a diversified conglomerate. That group spans drama production, two pay-TV channels (K-STAR, WeLike), talent management (TN Entertainment, Chorokbaem Entertainment, K Plus), a fried-chicken franchise and restaurants, and a leased observatory in Busan's Haeundae LCT tower. In 2023 the former chairman's alleged breach of trust led to a 21-month trading suspension and a KRX delisting decision. Q Capital Partners bought control in November 2024 and restored trading in April 2025. The company now presents as a PE-controlled turnaround: drama output nearly stopped in H1 2026, and non-content businesses currently supply most revenue. --- ### What the company does The company describes itself as Korea's representative drama producer operating six business divisions (company description via ValueLine, updated Q2 2026): 1. **Broadcast programme production.** Planning and producing dramas (and some variety programming) for terrestrial, general-programming (종편), cable and OTT platforms. 2. **Broadcast channel operation.** Running two pay-TV channels, K-STAR and WeLike. The company says they reach more than 95% of Korean pay-TV subscribers. 3. **Talent management.** Through subsidiaries Chorokbaem Entertainment (formerly Hook Entertainment) and TN Entertainment, plus an equity-accounted stake in model agency K Plus Holdings. 4. **Real estate rental.** Leasing the observatory in Busan's Haeundae LCT landmark tower. 5. **Media commerce.** 6. **F&B.** A fried-chicken franchise brand (후라이드참잘하는집, "Hoochamjal") and restaurant operations, run inside TN Entertainment. ### Business and revenue model | Revenue stream | Model | How revenue is earned | Margin character (evidence) | |---|---|---|---| | Drama production — commissioned (외주제작) | Project/service | The broadcaster or studio pays a production fee. The producer keeps sponsorship and PPL; IP usually stays with the broadcaster | Thin. Hanwha (Apr 2021) put typical gross margin at break-even to about 7% per title | | Drama production — own/partial IP (사전제작, IP 보유) | Licensing | Pre-produced titles sold to domestic and global OTTs by territory. Examples: *One Ordinary Day* to Coupang Play (Korea), Amazon Prime (Japan) and Viu (SE Asia/MENA/Africa); *My Liberation Notes* rights sold to Greater-China OTT (Q1 2023) | Higher upside but larger capital at risk. Impairments drove the FY2024 operating loss (FY2025 preliminary disclosure) | | Ancillary content | Licensing / royalty | OST, rights resale, sponsorship (협찬), PPL | Not separately disclosed | | Broadcast channels (K-STAR, WeLike) | Advertising + carriage | Ad sales and pay-TV carriage fees; in-house variety such as *Dokbak Tour* | About 9% of revenue in the 2026 H1/Q2 mix (Butler) | | Management | Service / commission | Artist appearance fees, events, music, endorsements | About 41% of revenue in the 2026 mix; KRW 20.0 bn in H1 2026 | | F&B | Franchise + direct sales | Franchise fees, product supply, company-run outlets | KRW 73.8 bn in FY2024 (35.1% of revenue, Dealsite); about 45% of the 2026 mix | | Rental | Lease | Observatory lease income at Haeundae LCT | About 5% of mix. Hanwha (Apr 2021) expected at least KRW 4 bn a year | **Product vs. service vs. licensing mix.** The company does not report revenue on this basis. On the 2026 H1/Q2 segment mix, about 86% of revenue came from services and franchise/retail (management plus F&B), about 9% from channel advertising and carriage, about 5% from leasing, and almost nothing from programme production or licensing. In FY2025, broadcast-programme revenue was KRW 43.4 bn, about 25% of consolidated revenue of KRW 172.2 bn (IB Tomato, Sep 2026; DART FY2025). ### Value-chain position and customers The company sits in the production (upstream) layer of the Korean broadcast value chain. Its owned channels give it a small presence in distribution, and its agencies give it a presence in talent supply. Former management called this an internalised chain of "planning → casting → production → distribution → secondary use" (Asia Economy, May 2023). Its customers fall into four groups: **B2B content:** broadcasters and studios such as SBS / Studio S, MBC, KBS, JTBC Studios, TV Chosun, tvN / CJ ENM Studios and High Ground, plus OTT platforms such as Netflix, Coupang Play, TVING, Wavve, Amazon Prime Video Japan, Viu and, from 2026, ReelShort. **Advertisers:** on the K-STAR and WeLike channels. **Event and endorsement buyers:** of artist services. **Consumers and franchisees:** for F&B, and observatory visitors indirectly through the lease. ### Independent characterisation The company calls itself an IP-led content house. The financials point to something else: a holding-style collection of mostly non-content cash flows (F&B, management, rental) with a drama business that has become intermittent. In H1 2026, broadcast-programme revenue was below KRW 0.1 bn against KRW 43.4 bn for the whole of FY2025 (IB Tomato, Sep 2026). Strategically, three things matter: rebuilding a drama pipeline, monetising the writer roster and library, and deciding whether to keep or sell the non-core businesses. Q Capital has already moved into a newspaper (Bridge Economy, July 2026) and short-form drama (ReelShort, June 2026). Those moves suggest a "general media group" plan rather than a return to pure production.

Revenue$0.1B
Employees49
Market CapN/A
Founded1998
United States, North America
OceanInW

Ocean In W Co., Ltd.

Premium
Information Technology

Ocean In W is a small KOSDAQ-listed holding and investment company. Its listed shell has a 30-year history in logistics, flat-glass distribution and Seoul real-estate leasing, and it serves as the main listed vehicle of the Won Young-sik family. From 2018 to 2024, under the names W Holding Company, Chorokbaem Company and CT Property, it was the controlling shareholder of K-drama producer Chorokbaem Media. Founder-related criminal proceedings forced the sale of that stake to Q Capital Partners in November 2024 for KRW 180 bn. Since then the company has operated as a cash-rich investment holding company. Its operating business is minimal (FY2025 consolidated revenue KRW 7.6 bn, operating loss KRW 2.5 bn), while consolidated equity is about KRW 289 bn. Capital has been redeployed into control stakes and secured loans via investment partnerships: Dimoa (software distribution), Jokwang ILI (industrial safety valves) and financing for the Initech acquisition. Governance and related-party exposure are the central analytical issues. --- ### Company's own description The company's Q3 2025 quarterly report (KIND) describes two reportable operating segments within the parent: a glass segment, which distributes architectural flat glass, window/curtain-wall sealants and related products, and a real-estate segment, which earns rental income. The KOSDAQ company profile (k5.co.kr reproduction) describes the business as glass distribution centred on architectural flat glass and window sealants, plus real-estate operations. Registry-based descriptions (JobKorea, Saramin) list a broader set of registered business objects: general merchandise wholesale, freight and multimodal transport, refrigerated and other storage, freight forwarding, shipping brokerage, civil engineering services and a model agency. Most of these are dormant legacy objects. Third-party profiles (Cookiedeal, THE VC) still list oil transport as a product line, but no oil-transport revenue appears in the 2025 segment disclosure. As of the latest disclosures, the consolidated group includes 13 subsidiaries, among them Jokwang ILI, Dimoa and A-Clean (에이클런) (StockPlus company summary). Several are held through wholly owned investment partnerships. ### Independent characterisation Economically, Ocean In W is now a listed investment holding company with a vestigial trading business: **Operating layer (small):** Glass wholesale and property rental produced KRW 5.73 bn of revenue in 9M 2025 (glass KRW 3.74 bn, 65.2%; real estate KRW 1.99 bn, 34.8%). Full-year FY2025 consolidated revenue was KRW 7.57 bn and the operating loss was KRW 2.45 bn (Digital Today, reproducing the FY2025 preliminary disclosure of 27 Feb 2026). **Capital layer (large):** Consolidated equity was KRW 286.3 bn at end-2024 and about KRW 288.9 bn at end-2025 (equity figure from the 15 Oct 2026 loan disclosure). The capital came mainly from the KRW 180 bn sale of Chorokbaem Media, which generated a FY2024 consolidated net profit of KRW 167.9 bn. **Deployment layer:** Since late 2024 the capital has gone into: (i) secured acquisition loans totalling KRW 41.7 bn to SJ 1st Holdings and SJ 2nd Holdings, the acquirers of KOSDAQ-listed security software firm Initech; (ii) control of KOSDAQ-listed software distributor Dimoa through SJ Holdings No.1 Investment Partnership (100% owned) and Aries No.1 Investment Partnership (99.99% owned); (iii) consolidation of industrial safety-valve maker Jokwang ILI (delisted from KOSDAQ in August 2025) at end-2025; and (iv) investment in Geolit Energy (formerly GN1 Energy) alongside entities linked to Won Sung-jun. ### Revenue model | Revenue type | Description | Approx. share of parent operating revenue (9M 2025) | |---|---|---| | Product (merchandise) sales | Wholesale of architectural float glass, processed glass, sashes and sealants | 65.2% | | Rental income | Leasing of owned Seoul commercial real estate | 34.8% | | Services / subscription / licensing | None disclosed | 0% | | Investment income (non-operating) | Interest on loans (e.g., 6.0% on SJ 1st/2nd Holdings loans), gains/losses on equity stakes, consolidation effects | Booked below operating line; drives net income | From FY2026 onward, consolidated revenue will also include manufactured products (safety valves and, via Jokwang ILI's subsidiary Daeyu, fertiliser and crop-protection products) and software distribution (Dimoa), depending on the consolidation dates in the FY2026 filings. ### Value-chain position, customers and end-markets **Glass:** A mid-stream distributor between float-glass manufacturers and processors/installers in Korean building construction. Customers are construction contractors, window/curtain-wall fabricators and glass processors (customer names not disclosed). The end-market is Korean residential and commercial construction. **Real estate:** Lessor of owned Gangnam-area commercial property. The M Building at 445 Dosan-daero is identified as a holding by Altss. Tenants are not disclosed. **Valves (Jokwang ILI, consolidated from end-2025):** Manufacturer of safety and pressure-reducing valves for shipbuilding equipment, power/nuclear plant equipment and process industries. Jokwang describes itself as Korea's leading domestic safety-valve maker. **Software distribution (Dimoa):** Reseller and distributor of commercial software licences to Korean enterprises.

Revenue$0.0B
Employees14
Market CapN/A
Founded1995
United States, North America
Choppies

Choppies Enterprises Limited

Premium
Information Technology

The legacy website in the list (choppies.co.bw) is still referenced by data vendors. The investor-relations site is choppiesgroup.com. Choppies Enterprises is Botswana's largest grocery retailer and, by its own description, the largest retailer in Southern Africa outside South Africa. It trades from about 314 stores in Botswana, Namibia and Zambia under the Choppies supermarket banner. Since the July 2023 acquisition of 76% of Kamoso Africa, it also runs the Liquorama liquor chain, Builders Mart hardware stores, and maize-milling and manufacturing operations. Group revenue reached roughly BWP 9.9 billion in FY2026. However, the model is a thin-margin, volume-driven value-retail franchise, with operating margins of about 2.5–3.5%. It is heavily exposed to Botswana's diamond-dependent consumer economy, which contributes close to 60% of revenue. After the 2018–2020 accounting crisis, a forced retreat from five countries, a 2023 recapitalisation and the 2024 Zimbabwe exit, Choppies is now a focused three-country operator. It is investing through a cyclical downturn: new stores, logistics and an ERP rollout. Earnings were roughly halved in FY2026 and the final dividend was suspended. --- ### What the company does Choppies is a multi-format mass-market retailer and distributor of fast-moving consumer goods (FMCG). Its product range covers: - dry groceries; - fresh produce, meat, bakery and deli; - household and personal-care goods; - liquor; - hardware and building materials; and - an emerging set of value-added financial and digital services. **Core grocery business.** The core grocery business trades as "Choppies" across store formats sized from small value stores to hyper stores. The format list has historically been described as Hyper, Super and Value stores (Listcorp/company profile), with five formats cited in 2024 commentary. Choppies has also piloted a cash-and-carry wholesale outlet. **Vertical integration.** The group is vertically integrated: - it operates its own distribution centres (10 DCs disclosed in 2024, Moneyweb/Profile); - it runs a commercial vehicle fleet (682 vehicles, FY2024 results presentation); - it has a fruit-and-vegetable DC and a beverages DC in Botswana [IAR25]; and - through Kamoso it owns maize milling and other manufacturing that supplies Choppies stores. At the time of the 2023 deal, Kamoso supplied about 60% of Choppies Botswana's requirements in its product categories (EquityAxis, July 2023). ### Company's own description (latest annual report themes) In its 2025 Integrated Annual Report and FY2025/HY2026 commentary, Choppies describes itself as follows [IAR25; HY26]: - a Botswana-based retail group with annual revenue above BWP 9 billion; - a leading position in Botswana and an expanding presence in Namibia and Zambia; - a grocery chain supplemented by the Liquorama liquor chain and Builders Mart hardware chain; - a business with a shared-value mandate: local sourcing from more than 5,600 farmers in its three countries, a BWP 4,000 per month living wage for Botswana employees from January 2025, and solar installations. ### Business and revenue model | Revenue stream | Share of FY2026 revenue | Model | Source | |---|---|---|---| | Retail sales (grocery, liquor, hardware) | About 99.3% (BWP 9.82 bn of about 9.89 bn) | Product retailing; cash-dominant consumer sales | [FY26-Res] | | Other revenue (wholesale, rentals, services, commissions) | About 0.7% | Product and service mix; not separately itemised in sources reviewed | Derived | | Other operating income (below revenue) | BWP 66 m in FY2025 | Rebates, rentals, sundry | [FY25] | **Revenue model mix.** Revenue is almost entirely product sales (more than 99%). There is no material subscription or licensing income. Financial services (bill payments, money transfer and similar) are described as "value-added financial services" (Simply Wall St company description). Their revenue contribution is not publicly disclosed. ### Value-chain position Choppies sits at the retail end of the FMCG chain, with partial backward integration into: - wholesale and distribution (own DCs, fleet and cash-and-carry); - primary processing (maize milling via Kamoso / "Rest of Choppies"); - produce sourcing (direct farmer procurement, supported by the Motopi farmers' app launched in FY2023). ### Customer types and end-markets | Customer / end-market | Description | |---|---| | Lower- and middle-income urban and peri-urban households | Core grocery shopper. About 2.3 million weekly customer visits disclosed in early 2024 (Business Weekly, CFO commentary, Feb/Mar 2024) | | Rural households | Choppies' Botswana network reaches small towns and villages, a historical differentiator | | Liquor consumers and on-trade / informal retailers | Liquorama operates both retail and wholesale liquor (Kamoso description, 2023) | | Builders, contractors and home-improvers | Builders Mart hardware | | Government-linked demand | Indirect: public-sector wages drive Botswana spending, and government austerity was cited as a FY2026 headwind [FY26-TS] | ### Independent characterisation Choppies is best understood as a Botswana consumer-cycle proxy with two growth options (Zambia and Namibia) and two turnaround options (Liquorama and Builders Mart). **Strengths.** The franchise's moat is density and logistics in Botswana, where it is the share leader. Its rural reach is hard to replicate. **Weaknesses.** - Its buying scale is small relative to Shoprite, whose FY2026 sales were about R270.8 bn. - Its gross margin of about 20.5% leaves little buffer against cost inflation. - The statutory living wage, IFRS 16 lease costs on new stores and promotional intensity are compressing EBIT. **FY2026 read-through.** FY2026 shows the model's sensitivity. Revenue grew 7.9% with zero volume growth, while expenses grew 12.1%. EBIT fell 23.6% [FY26-Res].

RevenueN/A
Employees12,900
Market CapN/A
Founded1986
United States, North America
Chong

Chong Kun Dang Holdings Corp.

Premium
Information Technology

The listing has not moved and the company has not changed its name since 2013. ### Identification Table | Item | Detail | |---|---| | Legal name | Chong Kun Dang Holdings Corp. (㈜종근당홀딩스) | | Former name | Chong Kun Dang Corp. (㈜종근당). The listed entity became the holding company and was renamed when the operating business was split off in November 2013. | | Founding | 7 May 1941 (Gungbon Pharmacy, the predecessor business), per company website | | Incorporation | Registered as a stock company in January 1956. Incorporated in the Republic of Korea. | | Headquarters | 8 Chungjeong-ro, Seodaemun-gu, Seoul (Chong Kun Dang Building). Tel. +82-2-6373-0600 | | Exchange / ticker | Korea Exchange, KOSPI: 001630 | | ISIN | KR7001630000 (standard KRX format for code 001630; confirm against the KRX register before use) | | CUSIP | Not applicable (no US listing) | | Fiscal year end | 31 December (FY2025 was the company's 71st fiscal period) | | Share capital | KRW 12,525 million at par value KRW 2,500. This implies about 5.01 million issued shares; about 4.76 million shares are outstanding excluding treasury stock. | | Employees (holding company, standalone) | 37 (S&P Global, latest); 35 (June 2026, TheVC). | | Employees (group context) | Chong Kun Dang (associate): about 2,346 (2025). Kyongbo Pharm: 575 (March 2026). CKD Healthcare: about 330. | | Auditor | — | | Market capitalisation | About KRW 178–183 bn (KRW 37,350 at 6 October 2026 on 4.76m outstanding shares, S&P Global; KRW 182.9 bn on issued-share basis, Butler) | | CEO | Choi Hee-nam, Representative Director (since 28 March 2024) | | Chairman / controlling shareholder | Lee Jang-han (33.73% direct stake) | | Website | www.ckd-holdings.com | CKD Holdings is the pure holding company at the apex of the Chong Kun Dang Group, one of South Korea's oldest pharmaceutical groups. The listed entity reports consolidated revenue of about KRW 959 bn (FY2025). Almost all of it comes from three healthcare subsidiaries: **CKD Healthcare:** (51%-owned, unlisted): consumer health functional foods. Its Lacto-Fit probiotic franchise made it the group's largest consolidated revenue line. **Kyongbo Pharm:** (43.41%, KOSPI): synthetic APIs and finished generics, now pivoting into antibody-drug conjugate (ADC) contract manufacturing. **CKD Bio:** (about 39%, KOSPI): fermentation APIs, probiotics and botulinum toxin. The group's flagship prescription-drug company, Chong Kun Dang Pharmaceutical (26.70%, KOSPI: 185750; FY2025 revenue KRW 1.69 tn), is equity-accounted rather than consolidated. A large share of the holding company's intrinsic value therefore sits outside its reported revenue line. The shares trade at a deep holding-company discount: about 0.2–0.3x book value and a price-to-earnings ratio of about 3–4x. Owner-family succession is actively under way, and this shapes capital allocation. --- ### What the Company Does CKD Holdings is a pure holding company (순수지주회사) under Korea's Monopoly Regulation and Fair Trade Act. Its own business activities are: - Owning and managing equity stakes in group companies. - Collecting brand royalties, dividends, rental and service fees. - Allocating capital, including stake purchases in subsidiaries and new investments. In March 2024 it added investment-related business purposes to its articles of incorporation. These cover investing in new-technology businesses, start-ups and SMEs, establishing new-technology finance subsidiaries, and accelerator activities. The change signals an intent to act as an investor, not only a passive parent (Dailypharm, 29 February 2024). ### Company's Own Description | Category | Affiliates | |---|---| | Healthcare | Chong Kun Dang, CKD Bio, Kyongbo Pharm, CKD Healthcare | | Real-estate leasing | CKD Industry | | Construction / environment | Bell E&C | | Services / transport | Bell SM (a family-owned affiliate, not a holding-company subsidiary) | | Marketing solutions | Bell Communications | | IT | Bell I&S | On its corporate website the company presents itself as follows: - It was launched in November 2013 when Chong Kun Dang converted to a holding-company structure to pursue a new leap as a global pharmaceutical group. - Its role is to maximise the value of operating companies, led by Chong Kun Dang, by concentrating on new business development and new investment. - It aims to find future growth engines and build a sustainable management system. The website lists its business line as "holding business and management consulting." It groups affiliates into six categories: Digital Daily (media) was added in 2025. ### Independent Characterisation Economically, CKD Holdings is best understood as three businesses plus an equity stake. 1. **A consumer-health company (CKD Healthcare).** It carries the consolidated income statement. It generated about 41% of consolidated revenue in Q2 2026. Profitability swings with marketing intensity in a saturated, promotion-heavy Korean supplements market. 2. **A B2B active-ingredient manufacturer (Kyongbo Pharm and CKD Bio).** Together these generated about 43% of Q2 2026 revenue. They sell synthetic and fermentation APIs to domestic and international drugmakers, including the group's own Chong Kun Dang. Both are adding higher-value platforms: ADC CDMO at Kyongbo and botulinum toxin at CKD Bio. 3. **Group services and property.** CKD Industry's real-estate leasing plus advertising, IT, construction and media affiliates generated about 14% of revenue. Holding-company royalty and fee income added about 2%. 4. **A 26.70% equity stake in Chong Kun Dang Pharmaceutical.** Chong Kun Dang is a top-tier Korean prescription-drug marketer and developer. It is accounted for by the equity method, so it appears as share of profit and long-term investments rather than revenue. Equity-method gains were about KRW 21.6 bn in FY2025 and KRW 21.8 bn in FY2024 (S&P Global cash-flow data). ### Revenue Model Mix | Revenue type | Main source | Approximate weight (Q2 2026, % of consolidated revenue) | |---|---|---| | Product sales – consumer (health functional foods, cosmetics) | CKD Healthcare | ~41% | | Product sales – B2B APIs and finished generics | Kyongbo Pharm | ~28% | | Product sales – fermentation APIs, probiotics, toxin | CKD Bio | ~15% | | Services / leasing / advertising / IT / media | CKD Industry and others | ~14% | | Brand royalty, fees, rent, dividends (holding-company level) | CKD Holdings standalone | ~2% | Source: Butler segment split (Q2 2026). Subscription or licensing revenue at consolidated level is negligible. Milestone and licence income such as the Novartis CKD-510 milestones accrues at Chong Kun Dang, the equity-accounted associate. ### Value-Chain Position, Customers and End-Markets | Business | Value-chain position | Main customers / channels | End-markets | |---|---|---|---| | CKD Healthcare | Branded consumer products, with own plant at Dangjin | Home shopping (29.8% of supplement sales in 2023, down from 42.2% in 2021), online, own mall, retail (including a past Daiso entry), agency network | Korean consumer health and wellness | | Kyongbo Pharm | Upstream API synthesis plus finished-dose generics; ADC CDMO under construction | Domestic pharma (including Chong Kun Dang), export API customers, hospitals and pharmacies for finished products | Antibiotics (cephalosporins), cardiovascular (atorvastatin), analgesics; ADC developers | | CKD Bio | Upstream fermentation API; probiotic raw materials and contract manufacturing; aesthetic toxin | Global and domestic drugmakers; health-food brands; aesthetic clinics | Transplant immunosuppression, anti-infectives, probiotics, aesthetics | | CKD Industry and others | Real-estate leasing, group services | Group companies and third parties | Property, advertising, IT, media |

Revenue$0.7B
Employees575
Market CapN/A
Founded1941
United States, North America
Choice

Choice NV

Premium
Information Technology

Choice NV is a Belgian micro-cap holding company whose listed shell now positions itself as a pure licensor of intellectual property for an asset-backed "complementary currency" project branded Good Money / Choice Coin (C²). The company originated in 2020 as the listed top-holding of the "Choice" project — a free, social-media-style personal TV guide that aggregated broadcast and online video into user-curated "virtual channels", combined with a group-purchasing service for internet and TV subscriptions. After failing to scale consumer traction (25,000 free users by January 2022), Choice pivoted in 2023–2024 to B2B direct-marketing software for food producers, booking its first-ever revenue (€1.075M, FY2024) from a licence to a related UAE entity. In 2025–2026 it re-pivoted again toward monetary technology. Its balance sheet (€69.1M assets) is almost entirely a €68.35M in-kind participation from founding, against a market value below €1M — the central tension of the investment case. --- ### Company's own description (latest, 2026) On its corporate website (choice.be, 2026), the company describes itself as a Belgian technology company at the frontier of monetary innovation that develops and licenses AI, blockchain and smart-contract technology powering a value-backed complementary currency, Good Money / Choice Coin (C²). It stresses that it does not issue or operate the currency itself and characterises its role, by analogy, as selling infrastructure rather than running the mine. The currency concept is described as being backed by a diversified basket of publicly traded value stocks selected on Benjamin Graham's intrinsic-value principles, redeemable against the underlying asset value, with an automated arbitrage mechanism aligning market price to net asset value. The 12 August 2026 MAR disclosure formalised this: the board repositioned Choice NV as a "pure licensing and holding company" that acts solely as licensor in the project using its intangible assets, holds no participation, board seat or veto right in any operating entity, and will limit its economic interest to an arm's-length licence fee once the operating entity has raised its own external capital (Choice NV press release, 12 Aug 2026). ### Prior descriptions (for continuity) **2020–2022 (consumer phase):** Choice was described as a free social-media TV guide letting consumers make their own selection from the full range of online video and available channels by sharing playlists as virtual channels, plus a group-purchasing platform for internet and TV at low tariffs (Euronext/Mondo Visione, Feb 2021; Choice PR, Dec 2022). **2024 (B2B food phase):** Choice described itself as, on the consumer side, a free personal TV guide and, on the business side, a direct-marketing platform with specialised virtual TV channels and integrated e-commerce, aiming to become an integrated technology supplier to food producers; its first vertical was direct marketing and sales of dairy products (Choice PR, 26 June 2024). **February 2025:** The company described a repositioning from video streaming/social media toward a B2B software platform for direct marketing and sales, while retaining a B2C mission through the "B2B2C Good Food Initiative" (Choice PR, 3 Feb 2025). ### Business model and revenue model | Dimension | Characterisation | |---|---| | Revenue model (current) | 100% licensing. FY2024 revenue (€1,075,000) comprised the fixed one-off portion of a software licence fee; a recurring and variable portion, expected to be an order of magnitude smaller, is contractually fixed (Choice PR, 3 Feb 2025). FY2025 revenue (€573,091): nature and counterparty not publicly disclosed. | | Product vs. service vs. subscription vs. licensing mix | Product: 0%; Service: 0%; Subscription: 0%; Licensing: 100% (FY2024–FY2025, analyst characterisation from filings and PRs). | | Envisaged future model | Licence to a Good Money operating entity/fund: USD 500,000 inception fee, USD 25,000 fixed annual fee, plus a 50% royalty on the gross fee revenues of the associated investment fund once operational — a mutual, non-binding, unsigned intention (Choice PR, 12 Aug 2026). | | Value-chain position | Upstream IP owner/licensor. Operating, regulatory and capital-raising functions sit in separate entities (e.g., Good Food Initiative FZ-LLC, UAE; future Good Money operating entities) in which Choice NV holds no stake. | | Customer types | Related-party licensees (GFI FZ-LLC, a "sister company" in which Choice Trust PRIV ST. took a strategic participation; Choice PR, 3 Feb 2025). Historically: consumers (free app users) and brands/advertisers (intended). | | End-markets (stated) | Monetary technology/complementary currency; food supply-chain/direct-to-consumer food marketing; online video discovery (legacy). | ### Independent characterisation In substance, Choice NV is a listed holding vehicle controlled by its founding family and related entities, with (a) a large, illiquid, related-party financial fixed asset (€68.35M participations from the 2020 in-kind contribution), (b) a small capitalised R&D intangible (€0.71M), (c) negligible working capital (€1,946 current assets at end-FY2025), and (d) revenue derived to date from licences to related parties. Revenue recognition has therefore depended on counterparties within the founder's orbit, and the commercial validation that third-party, arm's-length licensing would provide is still absent. The company itself states that it does not currently have sufficient working capital to fund all planned activities without additional financing (choice.be, FY2025 note).

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2020
Leuven, Belgium
Chobi

Chobi Company Limited

Premium
Information Technology

Chobi is one of the oldest compound-fertilizer manufacturers in South Korea. It was founded in 1955 and has belonged to the agrochemical group around Kyung Nong Corporation, part of the Dong-O group of companies. The company produces and distributes a broad range of compound and specialty fertilizers: basal and top-dressing compound fertilizers for rice, horticulture and fruit trees, bulk-blending (BB) fertilizers, controlled-release fertilizers (CRF) such as its "Danhanbeon" brand, fertigation, hydroponic and liquid fertilizers, and organic products. It holds licences for roughly 670 fertilizer products [S12]. Distribution relies heavily on the Nonghyup (NH) agricultural-cooperative procurement system, and the company held about a 9.7% share of the Korean fertilizer market at end-2021 [S9]. Chobi is small, with KRW 99.7bn revenue and about 107 employees. It is domestically focused, carries short-term debt and shows thin, volatile margins. Its points of difference are a long-established brand with NH, plants in Ulsan, Andong, Cheonan and Yeongdong, and a nascent biodegradable-coating CRF franchise developed with KRICT and Aekyung Chemical. --- ### What the company does Chobi manufactures and sells fertilizers. Raw nutrients, mainly imported nitrogen, phosphate and potash materials, are granulated, blended, coated or formulated into finished products for Korean agriculture, horticulture, forestry and turf. Morningstar's profile, drawn from company filings, describes the range as: - top-dressing compound fertilizers for horticulture, fruit trees and paddy rice; - bulk-blending fertilizers; - basal compound fertilizers for tobacco, peanuts, vegetables, garlic and onions, fruit trees, chestnuts, rice seedbeds, paddy rice, potatoes and turf [S29]. Other profiles add controlled-release compound fertilizers, fertigation compounds, sul-po-mag (sulphate of potash-magnesia), hydroponic compounds, liquid fertilizers, MCF organic fertilizers and "PNS CRF" fertilizers [S30][S31]. ### Company's own description (paraphrased from filings and quarterly report commentary) In its Q1 2022 quarterly report, cited by Asia Economy, Chobi described the industry as follows: - After two rounds of government-led industry rationalisation, about eight companies manufacture and sell fertilizers in Korea. - Chobi held about 9.7% of the overall fertilizer market at end-2021. - Its main products include controlled-release fertilizers such as "Danhanbeon" (단한번). - A large portion of its sales goes through the National Agricultural Cooperative Federation (NH) [S9]. A Korean investor data source summarises the company as a fertilizer maker founded on 15 November 1955 with private capital. Its stated purposes were the scientific modernisation of agriculture, soil improvement and production of quality fertilizers, and it listed on the securities market in 1976 [S12]. ### Business and revenue model | Dimension | Characterisation | Basis | |---|---|---| | Revenue type | Almost entirely product sales. In Q2 2026, manufactured fertilizer was 88% of revenue, traded (merchandise) fertilizer 4% and other 8% | [S7] | | Service / subscription / licensing | None identified | — | | Value-chain position | Mid-stream formulator and blender. Buys imported or domestic primary nutrients (urea, ammonium phosphates, potassium chloride and similar) and converts them into compound and specialty finished goods | [S1][S9]; analyst characterisation | | Primary channel | NH procurement (Nonghyup Economic Holdings, formerly the NH Central Federation), which resells to farmers through local cooperatives | [S9][S17][S18] | | Secondary channels | Commercial/retail market (시판), specialty horticulture and turf; small exports, e.g. biodegradable CRF to an Indonesian palm plantation | [S16]; analyst characterisation | | Customer types | Korean farmers (rice, horticulture, fruit, tobacco, vegetables); forestry; turf/golf; plantation agriculture (export) | [S29][S13] | | Seasonality | Strong. Revenue and profit peak in Q1–Q2 with spring application; Q3–Q4 are typically loss-making | [S3] | ### End-markets served 1. **Paddy rice:** basal, top-dressing and controlled-release fertilizers, including one-shot application products such as Danhanbeon. 2. **Horticulture and protected cultivation:** compound, fertigation, hydroponic and liquid fertilizers. 3. **Fruit trees and chestnuts:** dedicated compound fertilizers. 4. **Industrial crops:** tobacco and peanut compound fertilizers. 5. **Forestry and turf:** forestry-use and turf fertilizers [S13][S29]. 6. **Export plantation agriculture:** biodegradable CRF shipped to POSCO International's palm plantation in Indonesia (PT BIA) from July 2024 [S16]. ### Independent characterisation Chobi is a price-taker on inputs and a quasi-regulated seller on outputs. Its procurement costs move with global nitrogen, phosphate and potash prices and the KRW/USD rate. Much of its output is sold under NH supply contracts, where pricing is negotiated and volumes depend on NH's offtake. A 2021 contract filing stated explicitly that contracted quantities may change with NH's actual intake [S17]. As a result, gross margin depends on the timing between input-cost moves and NH price resets. This pattern is visible in FY2022 (windfall), FY2023 (inventory-cost squeeze, 9.5% gross margin) and FY2024–25 (normalisation at about 21%) [S1]. Strategically, the company is trying to move up the value chain into controlled-release and environmentally differentiated products, notably biodegradable bio-urethane coatings, where product differentiation can support better pricing than commodity blends [S14][S15].

Revenue$0.1B
Employees107
Market CapN/A
Founded1955
United States, North America
Cheongbo

Cheongbo Industrial. Co., Ltd

Premium
Information Technology

| Item | Detail | Source / note | |---|---|---| | Current legal name (Korean) | 청보 주식회사 | EGM 12 Jun 2026 (eDaily, 12 Jun 2026) | | Current legal name (English) | CHEONGBO INDUSTRIAL CO., LTD. | EGM agenda (Digital Today, 24 Apr 2026) | | Former names | 청보산업㈜ (to Jun 2021); 씨비아이㈜ / CBI Co., Ltd. (Jun 2021–Jun 2025); 더큐브앤㈜ / THE CUBE& Inc. (Jun 2025–Jun 2026) | Dealsite 8 Jun 2021; eDaily 12 Jun 2026 | | Founding | Incorporated December 1978 (first CEO: Ahn Hee-jeom). Company and press materials cite roots dating to 1959 ("62-year history" in 2021). | JobKorea corporate history; Dealsite 23 Mar 2021 and 10 Nov 2021. Discrepancy noted: 1959 = business origin per company PR; 1978 = incorporation per registry-based history | | Incorporation jurisdiction | Republic of Korea | — | | Headquarters | 208 Namdong-daero, Namdong-gu, Incheon (registered head office; EGM venue described as company headquarters) | Digital Today, 24 Apr 2026 | | Exchange / ticker | KOSDAQ (Korea Exchange): 013720 (KQ suffix in some terminals: 013720.KQ) | Google Finance; KRX | | KOSDAQ section | Moved from "Venture" to "Mid-sized company" section, December 2022 | JobKorea corporate history | | KOSDAQ listing date | Not publicly disclosed in sources reviewed | — | | ISIN | KR7013720008 (derived from KRX code using standard Korean ISIN construction and Luhn check digit; confirm with KSD) | Analyst derivation | | CUSIP | Not applicable (no US listing) | — | | Fiscal year end | 31 December | Valueline/Butler | | Employees | 36 (latest, per Google Finance; appears to reflect the listed entity). Historical: 97 regular employees before the 2020 change of control, 47 one year later | Google Finance (Oct 2026); DRCR analysis (2023) | | Employee 3-year trend | Not publicly disclosed in sources reviewed (consolidated headcount not available) | — | | Auditor | Not publicly disclosed in sources reviewed | Check latest DART audit report | | Share price | KRW 2,125 (16 Oct 2026, intraday 10:35 KST) | Google Finance | | Shares outstanding | 12,165,628 common shares (after 80% capital reduction effective 14 Jul 2026; previously 60,828,143) | Dealsite, 25 Aug 2026 | | Market capitalisation | approx. KRW 25.9 B (KRW 2,125 × 12.17M shares) | Google Finance (KRW 25.85 B); Valueline (KRW 25.9 B) | | 52-week range | KRW 1,450 – 6,200 (adjusted for capital reduction) | Google Finance | | Website | http://www.cheongbo.co.kr | Google Finance | | Largest shareholder | Growth & Value group (그로우스앤밸류13호투자조합 and related parties, 7.04% at end-2024; press in March 2026 refers to Growth & Value Development as current largest shareholder) | Dealsite, 29 Apr 2025; Nate/핀포인트, 19 Mar 2026 | | CEO | Oh Kyung-won (오경원), CEO since April 2021 | JobKorea corporate history; Google Finance | Cheongbo is a small Korean precision-castings and machining supplier of engine and transmission components — valve tappets, valve seat rings and guides, rocker arms, bearing journals, turbocharger base plates, tensioner bodies and transmission parts — sold predominantly for export to global commercial-vehicle and powertrain customers such as Daimler Truck and its US arm Detroit Diesel, BorgWarner (US and Mexico) and GM's South American operations, with domestic sales to construction- and agricultural-machinery engine makers. Its core manufacturing franchise is modest (consolidated revenue KRW 24.9 B in FY2025) but has been operating-profitable on most quarters since 2022. Since a 2020 change of control, however, the listed company has functioned as much as an investment and financing vehicle as a manufacturer, cycling through biotech (Kineta, Exicure), electric vans, tungsten mining, games and, most recently, MRO — funded by repeated mezzanine issuance. Persistent net losses, dilution and governance questions dominate the equity story. --- ### What the company does Cheongbo's revenue-generating business is the manufacture of automotive and off-highway engine and transmission components using casting (including precision casting introduced in 1981 and shell-mould casting) combined with CNC machining. Corporate-registry-style profiles list its principal items as insert chambers, rocker arms, ladder frames, valve seat rings, valve tappets and valve guides (Saramin/JobKorea company profiles). Press releases based on company statements add bearing journals (11 variants) for Daimler Truck's heavy-duty (HDEP) and medium-duty (MDEG) engine platforms, turbocharger base plates (2 variants) for the HDEP2020 platform, tensioner bodies for Chrysler's Pentastar V6 engine (supplied to BorgWarner), tappets and injector components, transmission parts for GM's South American passenger-car and pickup platforms, and engine parts for agricultural-machinery makers (Asia Business Daily, 22 Dec 2022; 23 Nov 2022; 19 Dec 2023). In the latest disclosed period (Q2 2026), automotive parts accounted for approximately 95% of revenue and "other" for approximately 5% (Butler, segment breakdown by Q2 2026 revenue). ### Business model and revenue model **Product model:** Essentially 100% product sales; no subscription, licensing or recurring service revenue is disclosed. Revenue is driven by platform-based, multi-year supply programmes: once a part is approved for an engine or vehicle platform, volumes run for the life of that platform (company commentary, Dealsite 26 Feb 2026). **Pricing:** Cost-plus with periodic renegotiation; in 2022 the company stated it achieved price increases of roughly 10–40% by item to pass through raw-material inflation (Dealsite, 16 Mar 2023). **Export orientation:** Management repeatedly stated that more than half of product revenue is exported, making results sensitive to the KRW/USD and KRW/EUR rates (Asia Business Daily, 19 Dec 2023; Dealsite, 26 Feb 2026). **Holding/investment overlay:** Since 2021 the listed company has also invested in, and accounted for, stakes in biotech, mining, EV and game companies, generating large equity-method, valuation and financing losses that dwarf operating profit. ### Value-chain position Cheongbo is a Tier-2/Tier-1 component supplier. For Daimler Truck/Detroit Diesel it supplies directly to engine plants (Germany, US, Japan, Brazil were named in 2021). For BorgWarner it supplies a component (tensioner body) that BorgWarner integrates into timing-drive systems for Chrysler engines. It sits upstream of OEM engine assembly and downstream of steel/iron scrap and alloy suppliers; raw materials represented roughly 39% of revenue on a trailing basis (raw materials KRW 10.4 B vs revenue KRW 26.8 B, TTM to Jun 2026, Valueline). ### Customer types and end-markets | End-market | Named customers (company statements) | Notes | |---|---|---| | Heavy/medium-duty truck diesel engines | Daimler Truck AG (Germany), Detroit Diesel Corporation (US) | HDEP, MDEG and HDEP2020 platforms; new next-gen MDEG parts ramp from Jun 2026 | | Passenger-car/light-truck powertrain | BorgWarner (US; Mexico from Nov 2023); GM South America (Brazil) | Exclusive supply of Pentastar tensioner body; GM GEM and GSV platform transmission parts | | Construction-equipment engines | HD Hyundai Infracore (formerly Hyundai Doosan Infracore); HD Hyundai Construction Equipment (HX12 hydrogen engine development) | Dealsite 16 May 2022; Money Today 26 Feb 2026 | | Domestic auto/engine | Hyundai Wia | Dealsite 10 Nov 2021 | | Agricultural machinery engines | Daedong, TYM, LS Mtron | Asia Business Daily 23 Nov 2022 | ### Company's own description vs independent characterisation **Company's description (paraphrased from 2023–2026 press materials):** a 60-plus-year-old materials-and-components specialist that directly supplies core parts to global OEM sites, pursuing market-share gains in main items, new part wins and customer diversification to become a "global hidden champion"; complemented by new growth businesses (successively: bio, electric commercial vehicles, UAM, tungsten, AI/games/blockchain, defence/aviation/MRO). **Independent characterisation:** a sub-scale (~KRW 25 B revenue) castings-and-machining supplier with genuine, sticky OEM relationships and thin operating margins (1–6% since 2022), attached to a listed shell that has been used since 2021 to raise and deploy mezzanine capital into unrelated ventures. The result is a business whose equity value is determined far more by financing structure, related-party transactions and investment write-downs than by its manufacturing operations. Korean financial media have described the company as a "convertible-bond factory" (DRCR, 2023) and questioned repeated additions of unrelated business purposes (Nate/핀포인트, 19 Mar 2026).

Revenue$0.0B
Employees36
Market CapN/A
Founded1978
United States, North America

Page 210 of 482

1…209210211…482

Page 210 of 482

Go to page
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo